WO2015041353A1 - Ring pessary for treatment of uterine prolapse or hysteroptosis - Google Patents

Ring pessary for treatment of uterine prolapse or hysteroptosis Download PDF

Info

Publication number
WO2015041353A1
WO2015041353A1 PCT/JP2014/074962 JP2014074962W WO2015041353A1 WO 2015041353 A1 WO2015041353 A1 WO 2015041353A1 JP 2014074962 W JP2014074962 W JP 2014074962W WO 2015041353 A1 WO2015041353 A1 WO 2015041353A1
Authority
WO
WIPO (PCT)
Prior art keywords
ring
pessary
string
resin
resin ring
Prior art date
Application number
PCT/JP2014/074962
Other languages
French (fr)
Japanese (ja)
Inventor
潤子 八木
Original Assignee
潤子 八木
八木 太郎
八木 茉莉
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 潤子 八木, 八木 太郎, 八木 茉莉 filed Critical 潤子 八木
Priority to JP2015537993A priority Critical patent/JPWO2015041353A1/en
Publication of WO2015041353A1 publication Critical patent/WO2015041353A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females
    • A61F6/08Pessaries, i.e. devices worn in the vagina to support the uterus, remedy a malposition or prevent conception, e.g. combined with devices protecting against contagion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/06Contraceptive devices; Pessaries; Applicators therefor for use by females

Definitions

  • the present invention relates to a uterine prolapse or uterine drop treatment ring used for the treatment of uterine prolapse or uterine ptosis, and more particularly to a uterine prolapse or uterine drop treatment ring that can be easily attached or detached by a patient.
  • a method for treating uterine prolapse or uterine ptosis a method using a “ring pessary” that is a ring-shaped therapeutic instrument is known (for example, Patent Document 1).
  • a ring pessary is installed at the upper end of the vagina to support the lower uterus with the ring pessary.
  • the ring pessary is mainly installed transvaginally in the upper part of the vagina in a medical institution, then periodically removed from the medical institution every several months, and installed again after washing.
  • vaginitis occurs due to treatment methods that leave ring pessaries in place for several months. Therefore, in order to prevent vaginitis, it has been proposed that the patient himself attach and detach the ring pessary every day at home. When a patient wakes up in the morning, he / she inserts a ring pessary by himself / herself and takes out the ring pessary before going to bed at night, thereby making vaginitis less likely.
  • an object of the present invention is to provide a ring pessary for treating uterine prolapse or uterus that is easy to attach and detach by the patient himself, has little pain at the time of attachment and detachment, and hardly damages the vagina.
  • the ring pessary of the present invention is A ring pessary for treating uterine prolapse or uterine droop for supporting the lower uterus and suppressing uterine prolapse or uterine drooping
  • the ring pessary includes a resin ring,
  • the outer diameter of the resin ring is 5 to 9 cm, and the load required to compress the outer diameter to 2 cm is 2 to 10 N.
  • the outer dimension of the resin ring 30 seconds after unloading is 70% or more of the outer diameter of the resin ring.
  • the resin ring can be compressed and deformed to an outer dimension of 2 cm only by applying a load of 2 to 10 N or less, so that the patient can attach and detach the ring pessary at home. Further, since the resin ring is inserted after being sufficiently deformed, the patient is less likely to feel strong pain when attaching / detaching the ring pessary, and the vagina is hardly damaged. Also, the resin ring used in the ring pessary of the present invention returns to 70% or more of the original outer diameter after 30 seconds after removing the load for compressive deformation. There is no loss of functionality.
  • FIG. 1A and 1B show a ring pessary according to Embodiment 1, in which FIG. 1A is a perspective view and FIG. 1B is a top view.
  • Fig.2 (a) is a schematic diagram which shows the state which installed the ring pessary which concerns on Embodiment 1 in the vagina upper end
  • FIG.2 (b) is the elements on larger scale of Fig.2 (a).
  • FIG. 3 is a top view of a resin ring used in the ring pessary according to the first embodiment.
  • FIGS. 4A and 4B are cross-sectional views of ring pessaries provided with resin rings having various cross-sectional shapes.
  • FIGS. 8A to 8C are cross-sectional views of ring pessaries provided with various forms of drug holding portions.
  • FIG. 9 is a top view of a ring pessary provided with a string.
  • FIG. 10 shows a ring pessary provided with a string attaching portion
  • FIG. 10 (a) is a perspective view
  • FIG. 10 (b) is a top view
  • Fig.11 (a) is a front view of the string for attaching to a ring pessary
  • FIG.11 (b) is sectional drawing for demonstrating the attachment method of a string
  • 12 (a) to 12 (b) are perspective views of a ring pessary provided with various types of string attaching portions.
  • 13A and 13B show a ring pessary provided with a protrusion, where FIG. 13A is a perspective view and FIG. 13B is a cross-sectional view.
  • FIG. 14A and 14B show another ring pessary provided with a protrusion, in which FIG. 14A is a perspective view and FIG. 14B is a cross-sectional view.
  • 15A and 15B show still another ring pessary provided with a protrusion.
  • FIG. 15A is a perspective view
  • FIG. 15B is a cross-sectional view.
  • 16A and 16B show still another ring pessary provided with a protrusion, wherein FIG. 16A is a perspective view and FIG. 16B is a cross-sectional view.
  • FIG. 17 is a hysteresis-loss curve of a resin ring used in the ring pessary of the present invention.
  • FIG. 18 is a hysteresis-loss curve of the resin ring of the comparative example.
  • the ring pessary 1 includes a resin ring 10.
  • the resin ring 10 shown in FIG. 1 has a shape in which a wide band-like body is used as a ring.
  • the dimension of the resin ring 10 is preferably determined based on the dimension of the body cavity (the dimension of the upper end of the vagina) in the horizontal direction when the resin ring 10 is upright (for example, the dimension of the upper end of the vagina).
  • the ring pessary 1 is placed at the upper end of the vagina 91 when the ring pessary 1 is used to treat uterine prolapse or uterine droop.
  • the resin ring 10 (particularly the outer surface 13) of the ring pessary 1 is held at the upper end of the vagina 91 by the surrounding soft tissue (vagina wall 95), and the upper surface 11 of the resin ring 10 is the uppermost end of the vagina 91. It comes into contact with the vaginal lid 93 (upward concave inner wall surrounding the uterine vagina part 94).
  • the ring pessary 1 can support the lower part of the uterus 90 from the lower side, it can prevent or treat uterine prolapse or uterine droop.
  • the resin ring 10 is more stably held in the vagina.
  • the resin ring 10 can also stimulate an organ (for example, the bladder 98 and the rectum 99) located around the upper end of the vagina 91. Therefore, the ring pessary 1 can also have an effect of suppressing bladder prolapse, frequent urination, constipation, and the like along with treatment of uterine prolapse or uterine droop.
  • pessaries early for example, after birth, at an early stage of uterine drooping
  • the ring pessary 1 is inserted into the upper end of the vagina 91 transvaginally from the direction of arrow X (FIG. 2A).
  • the resin ring 10 is compressed from the both sides in the diametrical direction with loads F 1 and F 2 so as to have an elongated shape like the resin ring 10 ′. It becomes very easy to insert. Since the diameter of the vagina of an adult woman is about 2 cm to 3 cm, the resistance when the resin ring 10 is inserted into the vagina 91 can be significantly reduced by deforming the resin ring 10 to 2 cm.
  • the ring pessary 1 can be inserted very easily. Therefore, the ring pessary 1 can be easily inserted even by a young mother.
  • a compressive load of 2 to 10 N is a small load that can be sufficiently applied by a female fingertip. Therefore, the female patient can deform the resin ring 10 with the fingertip. That is, when inserting the ring pessary 1, the patient can insert the resin ring 10 into the vagina after compressing the resin ring 10 to 2 cm with the patient's own fingertip.
  • the patient himself / herself can insert the fingertip into the vagina to sandwich the resin ring 10, compress the outer dimension DD of the resin ring 10 to 2 cm, and then pull it out.
  • the resin ring 10 can be sufficiently elongated when the ring pessary 1 is inserted and removed, the patient can insert and remove the ring pessary 1 without causing severe pain.
  • the outer diameter OD of the resin ring 10 means “the diameter of the outer surface 13 of the resin ring 10” when the resin ring 10 (circular shape before deformation) is viewed from above.
  • the second point on the outer surface 13 located on the opposite side through the center of the circle from the first point on the outer surface 13 of the resin ring 10. It is the distance to.
  • the outer dimension DD of the resin ring 10 refers to the minimum outer dimension of the resin ring 10 after deformation or unloading.
  • the resin ring 10 is completely unrestored when the resin ring 10 is unloaded after being deformed (when the resin ring 10 returns to the same circle as the original resin ring 10), the resin ring 10 after being deformed and restored is restored.
  • the “outer dimension DD” matches the “outer diameter OD” of the resin ring 10 before deformation.
  • the inventor of the present application has found that when the compressive load of the resin ring 10 is 2 to 10 N, the uterus can be sufficiently supported, so that a therapeutic effect on uterine prolapse or uterus is obtained. That is, the ring pessary 1 of the present invention can be sufficiently removed from the uterus or the uterus by using the soft and easily deformable resin ring 10 (previously considered to be unusable for the treatment of uterine prolapse or uterus).
  • the compressive load of the resin ring 10 is preferably 2 to 8N, and more preferably 3 to 5N.
  • the ring pessary 1 which can be easily inserted into the body and is suitable for treatment of uterine prolapse or uterine drooping can be provided.
  • the resin ring 10 used for the ring pessary 1 is required to return to a circular shape to some extent in a relatively short time after being inserted into the vagina and unloading the loads F 1 and F 2 . If the resin ring 10 does not return to a substantially circular shape, the resin ring 10 cannot fit well under the vaginal lid 93 and cannot support the uterus from below. Further, when the resin ring 10 is in the state of being elongated and deformed, the ring pessary 1 easily passes through the vagina 91 downward due to gravity and falls off the body. Therefore, the resin ring 10 needs an appropriate restoring force (a force for returning to the original shape after removing the load for deforming the resin ring 10).
  • the resin DD 10 has a restoring force such that the outer dimension DD of the resin ring 10 at 30 seconds after unloading is 70% or more of the outer diameter OD of the resin ring 10.
  • a restoring force such that the outer dimension DD of the resin ring 10 at 30 seconds after unloading is 70% or more of the outer diameter OD of the resin ring 10.
  • the resin ring 10 has a recovery rate of 70% or more 30 seconds after unloading, the resin ring 10 is positioned at a predetermined position under the vaginal lid 93 within 30 seconds after unloading and is held in that position. Therefore, the ring pessary 1 can be easily attached.
  • the restoration rate after 30 seconds after unloading is preferably 80% or more, and particularly preferably 90% or more.
  • the ring pessary 1 may include a soft film 20 that covers the opening 16 on the lower surface 12 side of the resin ring 10.
  • the soft film 20 FIG. 2 (a), ( b)
  • the lower part can be received by the soft film 20.
  • the lower film is received by the soft film 20.
  • Can do Thereby, the discomfort by the belt can be reduced. It can also be used during menstruation, and can also be used as a sanitary product for preventing uterine prolapse and uterine drooping.
  • vaginal tablets may be used in combination with ring pessary 1 for the treatment of vaginitis or for the prevention of vaginitis.
  • the ring pessary 1 having the soft film 20 is placed after putting the vaginal tablet in the upper end of the vagina, the vaginal tablet and the dissolved vaginal tablet dissolved in the vagina are held on the upper end of the vagina by the soft film 20.
  • the soft film 20 may be formed from a film that covers the lower surface of the resin ring 10 flatly. However, when the film is swollen downward as shown in FIG. Since it becomes easy to do, it is preferable.
  • the soft film 20 may be fixed to the lower surface 12 side of the resin ring 10 by adhesion, fusion, or the like. Moreover, you may fix the soft film 20 to the resin ring 10 by winding the edge part etc. of the soft film 20 around the resin ring 10 as a core material.
  • the compression load and the restoration rate of the resin ring 10 are the compression load and the restoration rate of the resin ring 10 measured with the soft film 20 for the following reason.
  • the compressive load of the resin ring 10 is defined so that the ring pessary 1 to be used can be easily inserted into the body.
  • the restoration rate of the resin ring 10 is defined so that the ring pessary 1 to be used is securely held at a predetermined position after being inserted into the body. That is, in the ring pessary 1 actually used, the resin ring 10 needs to have a predetermined compression load and a predetermined restoration rate.
  • the resin ring 10 provided with the soft film 20 needs to have the compression load and the restoration rate defined in the present invention.
  • the ring pessary 1 according to the present embodiment can have various additional configurations such as a medicine holding part, a string attaching part, and a protruding part.
  • the compressive load and the restoration rate of the resin ring 10 are the compressive load and the restoration rate of the resin ring 10 measured in a state having these additional configurations.
  • FIGS. 4 (a) to 4 (b) and FIGS. 5 (a) to 5 (b) show a ring pessary 1 including resin rings 10 having various cross-sectional shapes. These cross sections are cross sectional views taken along a line extending in the diameter direction of the resin ring 10 (specifically, a line AA in FIG. 1B).
  • the ring pessary 1 in FIG. 4A includes a resin ring 10 having a rectangular cross-sectional shape. A feature of the resin ring 10 having such a cross-sectional shape is that a flat outer surface 13 is provided.
  • the flat outer surface 13 contacts the vagina wall 95, so that the ring pessary 1 can be stably held at a predetermined position on the upper end of the vagina. Therefore, even when the compressive load of the resin ring 10 is small (that is, in the case of the resin ring 10 that is easily deformed), the ring pessary 1 that does not easily fall out of the body can be obtained.
  • the outer surface 13 of the resin ring 10 is pinched with two or more fingertips inserted into the vagina 91 and pulled out of the body.
  • the fingertip is less likely to slip when the outer surface 13 is pinched with the fingertip, as compared to the resin ring 10 having a circular cross-sectional shape (FIG. 4D). Therefore, the patient can easily take out the ring pessary 1.
  • the outer side surface 13 and the inner side surface 14 of the resin ring 10 have long sides and the upper surface 11 and the lower surface 12 have short sides.
  • the resin ring 10 having a width W (dimension in the z direction) larger than the thickness T (dimension in the diameter direction) of the resin ring 10 is preferable.
  • the ring pessary 1 in FIG. 4B is a modification of the ring pessary 1 in FIG. Specifically, an edge (outer upper edge) ED 1 between the outer surface 13 and the upper surface 11 and an edge (outer lower edge) ED 2 between the outer surface 13 and the lower surface 12 are chamfered with a curved surface. ing. Since the outer upper edge ED 1 and the outer lower edge ED 2 contact the vagina wall 95 when the ring pessary 1 is placed in the vagina (FIG. 2B), the edges ED 1 and ED 2 are chamfered. Thus, damage to the vagina wall 95 due to the edges ED 1 and ED 2 can be suppressed.
  • the edge between the inner side surface 14 and the upper surface 11 is also preferably chamfered with a curved surface. Since the inner upper edge ED 3 can come into contact with the vaginal lid 93 when the ring pessary 1 is placed in the vagina (FIG. 2B), the inner upper edge ED 3 is chamfered so that the inner upper edge ED 3 is chamfered. 3 can prevent the vaginal lid 93 from being damaged. Since the edge between the inner surface 14 and the lower surface 12 (inner lower edge ED 4 ) is less likely to contact the soft tissue in the vagina 91 than the other edges, the inner lower edge ED 4 is applied to the soft tissue in the vagina 91. Less likely to cause damage. However, since the soft tissue in the vagina 91 is delicate, it is preferable to chamfer the inner lower edge ED 4 with a curved surface to reliably avoid the risk of damaging the soft tissue.
  • the ring pessary 1 in FIG. 5A is a modification of the ring pessary 1 in FIG. 4B so that the edges ED 1 to ED 4 of the resin ring 10 are completely eliminated.
  • the characteristic of the ring pessary 1 in FIG. 5A is that the cross-sectional shape of the resin ring 10 includes a linear outer surface 13 and an upper surface 11 having a convex curve. Since the outer side surface 13 is straight (that is, the outer side surface 13 is flat), the effect of preventing the ring pessary 1 from falling off and the patient's own removal of the ring pessary 1 are easy as in the ring pessary 1 of FIG. Sexual effect is obtained.
  • the ring pessary 1 may include a resin ring 10 having a circular cross-sectional shape as shown in FIG.
  • FIG. 6A to 6 (b) show the ring pessary 1 provided with the soft film 20 having various shapes.
  • the ring pessary 1 in FIG. 6A has a shape in which the central portion of the soft film 20 extends downward ( ⁇ z direction).
  • the ring pessary 1 in FIG. 6B has a shape in which the entire soft film 20 is pulled downward about a point that is shifted from the center position in the y direction.
  • the resin ring 10 may include a medicine holding portion 18 for holding medicine. It is known that treatment with the ring pessary 1 is likely to cause vaginitis near the upper end of the vagina where the ring pessary 1 comes into contact. Drugs (eg, estriol) that are administered vaginally are used for the prevention of vaginitis or for the treatment after the onset of vaginitis. By inserting the ring pessary 1 into the vagina while holding such a drug in the drug holding part 18 of the resin ring 10, treatment of uterine prolapse or uterus and drug administration can be performed simultaneously. .
  • Drugs eg, estriol
  • the ring pessary 1 of the present invention can be attached and detached by the patient every day. Therefore, on the day when medication is required, the drug is placed in the drug holding unit 18 and then the ring pessary 1 is used, and no medication is required. Can use the ring pessary 1 without a drug. Since medication can be controlled in this way, unnecessary medication can be avoided.
  • a medicine to be put in the medicine holding part 18 various forms such as tablets, powders, jellys and the like can be used. It is easy for the patient to put the medicine in the tablet into the medicine holder 18. On the other hand, the amount of the powdery or jelly-like medicine can be easily adjusted in the medicine holding part 18.
  • FIG. 7 (a) to 7 (b) show concave drug holding portions 18 (181a, 181b) provided on the inner side surface 14 of the resin ring 10.
  • FIG. 1 When the medicine holding portion 18 is formed on the inner side surface 14, when the ring pessary 1 is placed in the vagina, the uterine vagina portion 94 (FIGS. 2A and 2B) fitted inside the resin ring 10 is provided.
  • the drug can be disposed in proximity, the therapeutic effect on the uterine vagina part 94 can be enhanced.
  • the drug holding part 181a shown in FIGS. 7 (a) to 7 (b) has an elliptical shape when viewed from the front, but is not limited to this, and is circular according to the ease of putting the drug, the dosage form of the tablet, etc. It can be a polygon (triangle, quadrangle, pentagon, etc.). Further, the medicine holding part 181a is not limited to a concave part having a constant depth as shown in the figure (that is, a concave part having a flat bottom surface), and may be a concave part whose depth changes. For example, when the tablet dosage form is rounded, a concave portion having a rounded bottom surface can be formed accordingly.
  • FIG. 7 (b) also shows a drug holding unit 181b for the purpose of suppressing tablet dropout as a modified example of the drug holding unit 181a.
  • the medicine holding part 181b has a dimension 181x of an opening opened on the inner surface 14 side slightly smaller than the outer dimension of the tablet, and a maximum dimension 181y of the medicine holding part 181b larger than the outer dimension of the tablet.
  • a soft film 20 When providing the medicine holding part 18 on the inner side surface 14 of the resin ring 10, it is preferable to provide a soft film 20.
  • a drug When a drug is put in the drug holding unit 18, powdered or jelly-like drugs may spill out from the drug holding unit 18, but if the soft film 20 is provided, the drug can be received by the soft film 20.
  • the ring pessary 1 After the ring pessary 1 is placed in the vagina, when the drug is dissolved in the body fluid, the dissolved drug is received by the soft film 20 so that it can be prevented from flowing out of the body.
  • the prevention of vaginitis or the vaginitis can heighten the effect of the treatment after a symptom. .
  • FIG. 8A shows concave drug holding portions 18 (182 a and 182 b) provided on the outer side surface 13 of the resin ring 10.
  • the medicine holding portion 18 is formed on the outer surface 14, the medicine is brought close to the vagina wall 95 (FIG. 2B) with which the outer surface 13 of the resin ring 10 contacts when the ring pessary 1 is disposed in the vagina. Therefore, the therapeutic effect on the vaginal wall 95 can be enhanced.
  • the shape of the concave portion (for example, the shape of the front view, the depth of the concave portion, etc.) constituting the medicine holding portion 182a shown in FIG. 8A is shown in FIGS. 7A to 7B. This is the same as the medicine holding unit 181a.
  • FIG. 8 (a) also shows a drug holding part 182b for the purpose of suppressing tablet dropout as a modified example of the drug holding part 182a.
  • the medicine holding part 182b has a dimension 182x of an opening opened on the outer surface 13 side slightly smaller than the outer dimension of the tablet, and a maximum dimension 181y of the medicine holding part 182b larger than the outer dimension of the tablet.
  • FIG. 8 (b) shows a drug holding portion 18 (183 a, 183 b) composed of a through hole penetrating from the inner side surface 14 to the outer side surface 13 of the resin ring 10. Since the medicine holding part 18 communicates with both the inner side surface 14 and the outer side face 13, the effect of the medicine holding part 181a shown in FIGS. 7A and 7B and the medicine holding part shown in FIG. Part 182a. That is, since the medicine holding part 18 shown in FIG. 8B communicates with the inner side surface 14, the therapeutic effect on the uterine vagina part 94 (FIG. 2B) fitted inside the resin ring 10 is enhanced. Can do. Furthermore, since the medicine holding portion 18 shown in FIG. 8B communicates with the outer side surface 13, the therapeutic effect on the vagina wall 95 (FIG. 2B) can be enhanced.
  • FIG. 8 (b) also shows a drug holding part 183b for the purpose of suppressing tablet dropout as a modified example of the drug holding part 183a.
  • the medicine holding part 183b has a dimension 183x of an opening opened on the inner side surface 14 side slightly smaller than the outer dimension of the tablet, a maximum dimension 183y of the medicine holding part 183b larger than the outer dimension of the tablet, and the outer side face 13
  • the dimension 183z of the opening that opens to the side is significantly smaller than the outer dimension of the tablet.
  • the dimension 181x of the opening on the inner surface 14 side is made significantly smaller than the outer dimension of the tablet, and the opening dimension 183z on the outer surface 13 side is set to the outer dimension of the tablet. It may be made slightly smaller. In addition, both the dimension 181x of the opening on the inner surface 14 side and the dimension 183z of the opening on the outer surface 13 side may be slightly smaller than the outer dimension of the tablet. Tablets can be inserted from the 13th side.
  • the soft film 20 is provided.
  • the powdery or jelly-like medicine may pass through the penetrating medicine holding part 183a and spill out from the inner side face 14 side.
  • the soft film 20 is provided, the drug can be received by the soft film 20.
  • the ring pessary 1 is placed in the vagina, when the drug is dissolved in the body fluid, the drug flowing out from the inner side surface 14 side is received by the soft film 20 so that it can be prevented from flowing out of the body.
  • the prevention of vaginitis or the vaginitis can heighten the effect of the treatment after a symptom. .
  • FIG. 7 (a) to 7 (b) and FIG. 8 (a) disclose a medicine holding portion 18 composed of a concave portion provided on the inner side surface 14 or the outer side surface 13, but this concave portion is elongated along the circumference. It can also be used as the chemical
  • FIG. 8C illustrates a groove-shaped medicine holding portion 18 (184) provided along the circumference of the inner side surface 14 of the resin ring 10.
  • a groove-shaped drug holding portion provided along the circumference of the outer side surface 13 of the resin ring 10 can also be provided.
  • the groove-shaped drug holding part 18 can be made larger than the concave drug holding part 18 so that the volume in which the drug can be put is wide, which is advantageous when it is desired to increase the dosage of the drug.
  • any number of tablets can be held at any place.
  • the ring pessary 1 can include a string 30 that is used when the ring pessary 1 is taken out from the vagina.
  • the string 30 has a rear end 31 firmly attached to an attachment position 190 of the resin ring 10, and a tip 32 is a free end that is not fixed.
  • the string 30 is arranged to extend from the resin ring 10 (FIG. 2A) held at the upper end of the vagina 91 to the outside of the body along the vagina 91. The patient can easily remove the ring pessary 1 by manually pulling the tip 32 of the string 30.
  • the resin ring 10 of the ring pessary 1 can be greatly deformed with a small compressive force, the resin ring 10 is pulled when the string 30 is pulled in the external direction (arrow P direction) with the ring pessary 1 placed at the upper end of the vagina 91. Is compressed from both sides by the vaginal wall 95 (FIG. 2 (a)) and deformed into an elongated shape (see the resin ring 10 ′′ indicated by the broken line). In such a deformed state, it can pass through the vagina 91 and be taken out of the body, so that no strong pain is felt when taking out. By providing the string 30, the ring pessary 1 can be taken out without inserting a finger into the vagina.
  • the string 30 having such a length that the tip 32 of the string 30 is sufficiently exposed outside the body so that the string 30 can be easily pulled.
  • the ring pessary 1 ′ (without the soft film 20) can include a string attachment portion 19 for attaching the string 30 to the resin ring 10.
  • 10A includes a through hole extending from the inner side surface 14 to the outer side surface 13 of the resin ring 10.
  • the string 30 can be fixed to the resin ring 10 by inserting the string 30 into the string attaching portion 19 and tying it.
  • the string 30 can be detachably attached to the resin ring 10 by being tied so that it can be unwound.
  • the string 30 may take any form, for example, as shown in FIG. 11A, the string 30 having the other end 31 formed into a ring may be used to facilitate attachment / detachment of the string 30. Can do.
  • a method for attaching the string 30 to the string attaching portion 19 will be described with reference to FIG. First, the tip 32 of the string 30 is inserted into the string attachment portion 19 from the inner surface 14 side of the resin ring 10 and pulled out to the outer surface 13 side. At this time, the ring at the rear end 31 of the string 30 is left protruding from the inner side surface 14 side of the resin ring 10. Thereafter, the tip 32 is directed to the inner surface 14 side through the lower surface 12 side of the resin ring 10.
  • the front end 31 of the string 30 is pulled downward after passing through the ring at the rear end 31 of the string 30 that is projected to the inner surface 14 side.
  • the string 30 can be easily attached to the string attaching part 19.
  • the knot of the string 30 is not located on the outer side surface 13 (contacts with the vagina wall) or the upper surface 11 (contacts with the vaginal vault) of the resin ring 10, it is difficult to damage the soft tissue in the vagina 91. Can do.
  • the string 30 can be attached / detached by providing the string attaching portion 19, the string 30 can be used properly according to the patient's proficiency with respect to the self attachment / detachment of the ring pessary 1. That is, while the patient is unaccustomed to self-removal of the ring pessary 1, the ring pessary 1 with the string 30 is used, and when the patient gets used to self-removal, the ring pessary 1 can be used without attaching the string 30. .
  • FIG. 12A a small annular protrusion can be provided on the lower surface 12 of the resin ring 10 to form the string attaching portion 19.
  • the string 30 may be tied to the hole (through hole portion of the annular protrusion) of the string attaching portion 19 after passing through the string 30.
  • FIG. 12B in the ring pessary 1 having the soft film 20 on the lower surface 12 of the resin ring 10, a hole can be made in the soft film 20 to form the string attaching portion 19.
  • the string 30 may be passed through the hole and then wound around the resin ring 10 before being tied.
  • the string attaching portion 19 is not limited to the form shown in FIGS. 11 to 12, and any form may be used as long as the string 30 can be attached to the resin ring 10.
  • two or more string attaching portions 19 are provided.
  • the deterioration of the string attachment portions 19 can be delayed and the life of the ring pessary 1 can be extended.
  • the center point O of the resin ring 10 and the first string attachment portions 19 (19a) when viewed from above.
  • the angle ⁇ is more preferably 80 to 100 °, and most preferably 90 °.
  • the resin ring 10 includes two string attaching portions 19a and 19b, and an angle ⁇ between the straight lines La and Lb passing through them is 90 °.
  • treatment is performed with the ring pessary 1 in which the string 30 is fixed to the first string attachment portion 19a.
  • the treatment is performed with the ring pessary 1 in which the string 30 is fixed to the second string attachment portion 19b.
  • the resin ring 10 When the first day of treatment is completed and the ring 30 is removed from the body by pulling the string 30 attached to the first string attaching part 19a, the resin ring 10 is moved to the first straight line passing through the first string attaching part 19a. It is deformed into a shape elongated in the La direction (y direction) (see the resin ring 10a shown by a broken line). At this time, the resin ring 10 is pulled in the y direction and compressed in the x direction. When the second day of treatment is completed and the ring 30 is removed from the body by pulling the string 30 attached to the second string attachment part 19b, the resin ring 10 becomes a second straight line passing through the second string attachment part 19a.
  • “Internal strain” may remain in the resin ring 10 due to the tensile stress in the y direction and the compressive stress in the x direction applied to the resin ring 10 on the first day of treatment. However, the “internal strain” generated on the first day of treatment is canceled or alleviated by the compressive stress in the y direction and the tensile stress in the x direction applied to the resin ring 10 on the second day of treatment. Become. Thereby, the internal strain of the resin ring 10 is less likely to remain in the long term, and the life of the ring pessary 1 can be extended.
  • angle (theta) 90 degrees
  • angle (theta) is not limited to 90 degrees.
  • angle ⁇ 120 ° (that is, when three string attachment portions 19 are provided at equal intervals on the resin ring 10)
  • the string 30 is attached to the first string attachment portion
  • the internal strain of the resin ring 10 can be offset or alleviated by treatment for three days.
  • the angle ⁇ 60 ° (that is, when six string attaching portions 19 are provided at equal intervals on the resin ring 10)
  • the internal strain of the resin ring 10 can be offset or alleviated by treatment for 6 days. .
  • the patient himself changes the lace attachment portion 19 to which the lace 30 is attached every day to treat the uterine prolapse or uterus with the ring pessary 1 for 2 to 6 days. It is possible to cancel or alleviate the internal strain of the resin ring 10 only by performing it.
  • the ring pessary 1 can include a rod-shaped protrusion 22 that is used when the ring pessary 1 is taken out from the vagina.
  • the protrusion part 22 can be formed from the rod-shaped member of various forms, such as a rectangle, circular shape, and an ellipse, in cross section.
  • the protrusion 22 may be hollow or solid.
  • the rod-shaped protrusion 22 can be provided on the ring pessary 1 with one end fixed to the lower surface 21 of the soft film 20 and the other end extending downward.
  • the lower surface 21 of the soft film 20 is disposed on the vagina 91 side, and the protrusion 22 fixed to the lower surface 21 of the soft film 20 It protrudes downward.
  • a finger is inserted into the vagina, and the protrusion 22 is grasped and pulled by the fingertip. Since the protrusion 22 protrudes downward in the vagina 91, if the finger is inserted into the vagina 91 shallowly, the protrusion 22 can be grasped by the fingertip. Therefore, the ring pessary 1 can be taken out relatively easily even by an inexperienced patient.
  • a slip stopper 23 can be provided on the surface of the protrusion 22.
  • the anti-slip 23 can be in various forms such as a belt-like convex portion provided on the surface of the protruding portion 22, an island-shaped convex portion, and a groove portion.
  • a non-slip 23 comprising a belt-like convex portion extending around the rod-like projection 22 is preferable.
  • a string used when the ring pessary 1 is taken out can be attached to the protrusion 22.
  • a string can be tied to the protrusion 22.
  • the string can be extended from the protrusion 22 along the vagina 91 to the outside of the body.
  • the patient can pull out the ring pessary 1 by pulling the protrusion 22 through the string by manually pulling the end of the string exposed outside the body.
  • the protrusion 22 is provided with the anti-slip 23, it is preferable that a string is tied to the protrusion 22 above the anti-slip 23.
  • the protrusion 22 is fixed at the center position of the flexible film 20, but is not limited to this.
  • the protrusion 22 may be fixed to the soft film 20 at a position shifted from the center in the y direction of the soft film 20.
  • the protrusion 22 in addition to the form in which the protrusion 22 extends vertically downward, the protrusion 22 can be inclined and extended as shown in FIG.
  • the ring pessary 1 with the protruding portion 22 inclined as described above is mounted, the ring pessary 1 is preferably installed in the vagina 91 so that the inclined direction of the protruding portion 22 coincides with the front side of the body.
  • the protrusion direction (downward front side of the body) of the protrusion 22 can be adapted to the anatomical form of the lumen of the vagina 91 (inclined downward from the vagina toward the vaginal opening). Further, when the ring pessary 1 is taken out from the vagina 91, the protrusion 22 extends in the same direction as the lumen of the vagina 91, so that it is easy to pull the protrusion 22 along the anatomy of the vagina 91. The ring pessary 1 can be taken out smoothly.
  • the protrusion 22 can be provided on the soft film 20 having a portion extending downward.
  • the ring pessary 1 shown in FIG. 15 has a soft film 20 having a configuration as shown in FIG. 6A, and a protrusion 22 is fixed to the lowest point of the soft film 20 (near the center of the extended portion).
  • the ring pessary 1 of FIG. 16 it has the soft film 20 of the form as shown in FIG.6 (b), and is at the lowest point of the soft film 20 (point shifted from the center position of the soft film 20 in the y direction).
  • the protrusion 22 is fixed.
  • the protrusion 22 is located in the vicinity of the vaginal opening, so when removing the ring pessary 1 from the body, just inserting the finger shallowly near the vaginal opening, The protrusion 22 can be grasped with a fingertip. Therefore, the ring pessary 1 can be easily taken out even by an inexperienced patient.
  • the resin ring 10 is a ring-shaped member having a through hole inside.
  • the resin ring 10 is formed of a biocompatible elastic material, and for example, a polymer material such as silicone rubber, nylon, and polyvinyl chloride is suitable.
  • the soft film 20 is for receiving a liquid or the like by covering the hollow portion inside the resin ring 10 from the lower surface 11 side. Since the flexible film 20 receives liquid, it is basically desirable that there is no hole. However, since the amount of liquid to be received is not so large, for example, for the purpose of providing the string attaching portion 19, a hole may be partially formed. In addition, when opening a hole, avoiding the center of the soft film 20 and making it in the vicinity of the resin ring 10, it is difficult to impair the function of receiving the liquid. It is preferable that the flexible film 20 is molded into a shape that hangs down at the center, because the liquid can be easily received.
  • the flexible film 20 is made of a biocompatible film material, and a polymer material film such as a silicone rubber film, a nylon film, or a polyvinyl chloride film is preferable.
  • the protrusion 22 and the anti-slip portion 23 are made of a biocompatible material, and for example, a polymer material such as silicone rubber, nylon, polyvinyl chloride, and thermoplastic elastomer is suitable.
  • a polymer material such as silicone rubber, nylon, polyvinyl chloride, and thermoplastic elastomer is suitable.
  • the protrusion 22 and the anti-slip 12 may be made of a material different from that used for the soft film 20. In that case, what is necessary is just to shape
  • the string 30 is used to make it easy for the patient to take the ring pessary 1 out of the body.
  • the string 30 is formed of a material having a sufficiently high tensile strength so that the string 30 is not cut during the removal of the ring pessary 1.
  • the string 30 is a member that contacts body fluid, it is preferably formed from a material that does not easily cause problems such as a decrease in tensile strength due to contact with the body fluid.
  • the string 30 is made of a material having a certain thickness and softness so as not to damage the vagina wall 95 and the like when moving in the vagina 91.
  • the string 30 is formed from a biocompatible string-like material, for example, a string-like material made of a natural material such as cotton or silk, or a polymer material such as a silicone rubber film, nylon, or polyvinyl chloride film.
  • a string-like material is preferred.
  • Example 1 About the resin ring 10 used for the ring pessary 1, the compression load required to make the outer dimension 2 cm was measured.
  • a silicone rubber resin ring 10 was used as a measurement sample.
  • the compression load of the resin ring 10 was measured in accordance with JIS K 6254: 2010 “Vulcanized rubber and thermoplastic rubber-Determination of stress / strain characteristics”. In the measurement, a load was applied to the resin ring 10 in the diameter direction (loading process), and the outer dimension was compressed from 7 cm (no load) to 2 cm (displacement 5 cm). Thereafter, the load was gradually reduced (unloading process).
  • the test speed (deformation speed of the outer dimension) was 20 cm / min. That is, the loading process was 15 seconds and the unloading process was 15 seconds.
  • FIG. 17 is a hysteresis-loss curve showing the loading process and the unloading process.
  • the load required to make the displacement 5 cm was 5.34 N (about 0.54 kgf).
  • Comparative Example 1 As a comparative example, for a commercially available ring pessary (made by Kitasato Medical Co., Ltd., trade name “Kitaza Tring Pessary”), a compressive load necessary to make the outer dimension 2 cm was measured.
  • the ring pessary used was a nylon resin contract O-type ring pessary (hereinafter referred to as “ring sample”).
  • the compression load measurement of the ring sample was the same as in Example 1.
  • FIG. 18 is a hysteresis-loss curve showing the loading process and the unloading process.
  • the load required to make the displacement 5 cm was 37.5 N (3.82 kgf).
  • the resin ring 10 of Example 1 has a compression load of 5.34 N (about 550 g in terms of weight). It can be seen that it can be sufficiently deformed.
  • the ring sample of Comparative Example 1 has a compressive load of 37.5 N (a little less than 4 kg in terms of weight), and it can be seen that it cannot be easily deformed by the fingertip of a female patient.

Abstract

Provided is a ring pessary (1) for the treatment of uterine prolapse or hysteroptosis, the ring pessary (1) being used to control uterine prolapse or hysteroptosis by supporting the lower uterine segment. The ring pessary (1) is characterized in that: the ring pessary (1) includes a resin ring (10); the resin ring (10) has an outer diameter (OD) of 5-9 cm, and the load necessary to compress the outer diameter to 2 cm is 2-10 N; and the external dimension of the resin ring 30 seconds after the load is removed is at least 70% of said outer diameter of the resin ring.

Description

子宮脱又は子宮下垂治療用リングペッサリーRing pessary for uterine prolapse or uterine droop treatment
 本発明は、子宮脱又は子宮下垂の治療に用いられる子宮脱又は子宮下垂治療用リングに関し、特に、患者自身による着脱が容易な子宮脱又は子宮下垂治療用リングに関する。 The present invention relates to a uterine prolapse or uterine drop treatment ring used for the treatment of uterine prolapse or uterine ptosis, and more particularly to a uterine prolapse or uterine drop treatment ring that can be easily attached or detached by a patient.
 子宮脱又は子宮下垂の治療方法として、リング状の治療器具である「リングペッサリー」を用いる方法が知られている(例えば、特許文献1)。治療においては、膣上端にリングペッサリーを設置することにより、リングペッサリーで子宮下部を支持する。これにより、子宮脱又は子宮下垂の治療及び予防をすることができる。
 リングペッサリーは、主に、医療機関において経膣的に膣上部に設置された後、数ヶ月ごとに医療機関で定期的に抜去して、洗浄後に再度に設置される。
As a method for treating uterine prolapse or uterine ptosis, a method using a “ring pessary” that is a ring-shaped therapeutic instrument is known (for example, Patent Document 1). In treatment, a ring pessary is installed at the upper end of the vagina to support the lower uterus with the ring pessary. Thereby, treatment and prevention of uterine prolapse or uterine drooping can be performed.
The ring pessary is mainly installed transvaginally in the upper part of the vagina in a medical institution, then periodically removed from the medical institution every several months, and installed again after washing.
特開2011-167364号公報JP 2011-167364 A
 近年、リングペッサリーを数ヶ月設置したままにする治療方法が原因で、膣炎が起こることが報告されている。そこで、膣炎を予防するために、患者自身が自宅でリングペッサリーを毎日着脱することが提案されている。患者は、朝起きたら自身でリングペッサリーを挿入し、夜寝る前にリングペッサリーを取り出すことにより、膣炎が起こりにくくなる。 In recent years, it has been reported that vaginitis occurs due to treatment methods that leave ring pessaries in place for several months. Therefore, in order to prevent vaginitis, it has been proposed that the patient himself attach and detach the ring pessary every day at home. When a patient wakes up in the morning, he / she inserts a ring pessary by himself / herself and takes out the ring pessary before going to bed at night, thereby making vaginitis less likely.
 しかしながら、従来は、比較的硬質で変形しにくいリングペッサリーを使用することにより、効果的な子宮脱又は子宮下垂の治療が行えるものと考えられていた。そのような硬質で変形しにくいリングペッサリーは、患者自身が着脱できるものではなかった。また、子宮脱又は子宮下垂の主な患者は中高年の経産婦であるが、未経産婦や若年の経産婦の患者もいる。未経産婦の場合、硬質で変形しにくいリングペッサリーを経膣的に挿入するのは極めて困難で、患者は強い痛みに耐えることを強いられていた。 However, conventionally, it has been considered that the use of a ring pessary that is relatively hard and difficult to deform can effectively treat uterine prolapse or uterus. Such a hard and difficult to deform ring pessary has not been detachable by the patient himself. In addition, the main patients with uterine prolapse or uterine ptosis are middle-aged and older women, but there are also those who have been born or young. In the case of a naive woman, it was extremely difficult to insert the ring pessary that is hard and difficult to deform vaginally, and the patient was forced to withstand severe pain.
 そこで、本発明は、患者自身による着脱が容易で、着脱時の痛みが少なく且つ膣を傷つけることが極めて少ない子宮脱又は子宮下垂治療用のリングペッサリーを提供することを目的とする。 Therefore, an object of the present invention is to provide a ring pessary for treating uterine prolapse or uterus that is easy to attach and detach by the patient himself, has little pain at the time of attachment and detachment, and hardly damages the vagina.
 本発明のリングペッサリーは、
 子宮下部を支持して子宮脱又は子宮下垂を抑制するための子宮脱又は子宮下垂治療用リングペッサリーであって、
 前記リングペッサリーは樹脂リングを含み、
 前記樹脂リングの外直径が5~9cmで、前記外直径を2cmまで圧縮するのに必要な荷重が2~10Nであり、
 除荷後30秒における前記樹脂リングの外寸法が、前記樹脂リングの前記外直径の70%以上であることを特徴とする。
The ring pessary of the present invention is
A ring pessary for treating uterine prolapse or uterine droop for supporting the lower uterus and suppressing uterine prolapse or uterine drooping,
The ring pessary includes a resin ring,
The outer diameter of the resin ring is 5 to 9 cm, and the load required to compress the outer diameter to 2 cm is 2 to 10 N.
The outer dimension of the resin ring 30 seconds after unloading is 70% or more of the outer diameter of the resin ring.
 本発明のリングペッサリーでは、樹脂リングは、2~10N以下の荷重をかけるだけで外寸法を2cmまで圧縮変形させることができるので、患者自身が自宅でリングペッサリーの着脱を行うことができる。また、樹脂リングを十分に変形させた後に挿入するので、患者はリングペッサリー着脱時に強い痛みを感じるおそれが少なく且つ膣を傷つけることが極めて少ない。
 また、本発明のリングペッサリーに使用される樹脂リングは、圧縮変形させるための荷重を取り除いて30秒後には元の外直径の70%以上まで戻るので、挿入時に大きく変形させてもリングペッサリーの機能を損なうことはない。
In the ring pessary of the present invention, the resin ring can be compressed and deformed to an outer dimension of 2 cm only by applying a load of 2 to 10 N or less, so that the patient can attach and detach the ring pessary at home. Further, since the resin ring is inserted after being sufficiently deformed, the patient is less likely to feel strong pain when attaching / detaching the ring pessary, and the vagina is hardly damaged.
Also, the resin ring used in the ring pessary of the present invention returns to 70% or more of the original outer diameter after 30 seconds after removing the load for compressive deformation. There is no loss of functionality.
図1は、実施の形態1に係るリングペッサリーを示しており、図1(a)は斜視図、図1(b)は上面図である。1A and 1B show a ring pessary according to Embodiment 1, in which FIG. 1A is a perspective view and FIG. 1B is a top view. 図2(a)は、実施の形態1に係るリングペッサリーを膣上端に設置した状態を示す模式図であり、図2(b)は図2(a)の部分拡大図である。Fig.2 (a) is a schematic diagram which shows the state which installed the ring pessary which concerns on Embodiment 1 in the vagina upper end, FIG.2 (b) is the elements on larger scale of Fig.2 (a). 図3は、実施の形態1に係るリングペッサリーに使用される樹脂リングの上面図である。FIG. 3 is a top view of a resin ring used in the ring pessary according to the first embodiment. 図4(a)~(b)は、様々な断面形状を有する樹脂リングを備えているリングペッサリーの断面図である。FIGS. 4A and 4B are cross-sectional views of ring pessaries provided with resin rings having various cross-sectional shapes. 図5(a)~(b)は、様々な断面形状を有する樹脂リングを備えているリングペッサリーの断面図である。FIGS. 5A and 5B are cross-sectional views of a ring pessary provided with resin rings having various cross-sectional shapes. 図6(a)~(b)は、様々な形状を有する軟質フィルムを備えているリングペッサリーの断面図である。6 (a) to 6 (b) are cross-sectional views of a ring pessary provided with a flexible film having various shapes. 図7(a)は、薬剤保持部を備えたリングペッサリーの斜視図であり、図7(b)は、図7(a)のB-B線におけるリングペッサリーの断面図である。FIG. 7A is a perspective view of a ring pessary provided with a medicine holding portion, and FIG. 7B is a cross-sectional view of the ring pessary along the line BB in FIG. 7A. 図8(a)~(c)は、様々な形態の薬剤保持部を備えたリングペッサリーの断面図である。FIGS. 8A to 8C are cross-sectional views of ring pessaries provided with various forms of drug holding portions. 図9は、紐を備えたリングペッサリーの上面図である。FIG. 9 is a top view of a ring pessary provided with a string. 図10は、紐取付け部を備えたリングペッサリーを示しており、図10(a)は斜視図、図10(b)は上面図である。FIG. 10 shows a ring pessary provided with a string attaching portion, FIG. 10 (a) is a perspective view, and FIG. 10 (b) is a top view. 図11(a)は、リングペッサリーに取り付けるための紐の正面図であり、図11(b)は、紐の取付け方法を説明するための断面図である。Fig.11 (a) is a front view of the string for attaching to a ring pessary, and FIG.11 (b) is sectional drawing for demonstrating the attachment method of a string. 図12(a)~(b)は、様々な形態の紐取付け部を備えているリングペッサリーの斜視図である。12 (a) to 12 (b) are perspective views of a ring pessary provided with various types of string attaching portions. 図13は、突起部を備えたリングペッサリーを示しており、図13(a)は斜視図、図13(b)は断面図である。13A and 13B show a ring pessary provided with a protrusion, where FIG. 13A is a perspective view and FIG. 13B is a cross-sectional view. 図14は、突起部を備えた別のリングペッサリーを示しており、図14(a)は斜視図、図14(b)は断面図である。FIGS. 14A and 14B show another ring pessary provided with a protrusion, in which FIG. 14A is a perspective view and FIG. 14B is a cross-sectional view. 図15は、突起部を備えたさらに別のリングペッサリーを示しており、図15(a)は斜視図、図15(b)は断面図である。15A and 15B show still another ring pessary provided with a protrusion. FIG. 15A is a perspective view, and FIG. 15B is a cross-sectional view. 図16は、突起部を備えたまたさらに別のリングペッサリーを示しており、図16(a)は斜視図、図16(b)は断面図である。16A and 16B show still another ring pessary provided with a protrusion, wherein FIG. 16A is a perspective view and FIG. 16B is a cross-sectional view. 図17は、本発明のリングペッサリーに使用される樹脂リングのヒステリシス-ロス曲線である。FIG. 17 is a hysteresis-loss curve of a resin ring used in the ring pessary of the present invention. 図18は、比較例の樹脂リングのヒステリシス-ロス曲線である。FIG. 18 is a hysteresis-loss curve of the resin ring of the comparative example.
 以下、図面に基づいて本発明の実施の形態を詳細に説明する。なお、以下の説明では、必要に応じて特定の方向や位置を示す用語(例えば、「上」、「下」、「右」、「左」及び、それらの用語を含む別の用語)を用いる。それらの用語の使用は図面を参照した発明の理解を容易にするためであって、それらの用語の意味によって本発明の技術的範囲が限定されるものではない。また、複数の図面に表れる同一符号の部分は同一の部分又は部材を示す。 Hereinafter, embodiments of the present invention will be described in detail with reference to the drawings. In the following description, terms indicating specific directions and positions (for example, “up”, “down”, “right”, “left” and other terms including those terms) are used as necessary. . The use of these terms is to facilitate understanding of the invention with reference to the drawings, and the technical scope of the present invention is not limited by the meaning of these terms. Moreover, the part of the same code | symbol which appears in several drawing shows the same part or member.
<実施の形態1>
 図1に示すように、本実施の形態に係るリングペッサリー1は樹脂リング10を含んでいる。図1に示す樹脂リング10は、幅広の帯状体を輪にした形状にされている。樹脂リング10の寸法は、直立時の水平方向における(樹脂リング10が配置される)体内腔の寸法(膣上端の寸法)に基づいて決定するのが好ましく、例えば外直径OD=5~9cm、幅W(z方向の寸法)=0.5cm~1cm、厚さT(直径方向の寸法)=0.2cm~0.6cmにすることができる。
<Embodiment 1>
As shown in FIG. 1, the ring pessary 1 according to the present embodiment includes a resin ring 10. The resin ring 10 shown in FIG. 1 has a shape in which a wide band-like body is used as a ring. The dimension of the resin ring 10 is preferably determined based on the dimension of the body cavity (the dimension of the upper end of the vagina) in the horizontal direction when the resin ring 10 is upright (for example, the dimension of the upper end of the vagina). The width W (dimension in the z direction) = 0.5 cm to 1 cm and the thickness T (dimension in the diameter direction) = 0.2 cm to 0.6 cm.
 図2に示すように、リングペッサリー1による子宮脱又は子宮下垂の治療の際には、リングペッサリー1は、膣91の上端に配置される。このとき、リングペッサリー1の樹脂リング10(特に外側面13)が、周囲の軟組織(膣壁95)によって膣91の上端に保持され、樹脂リング10の上面11が、膣91の最上端である膣円蓋93(子宮膣部94を取り囲む上向きの凹状内壁)に接触する。これにより、リングペッサリー1は、子宮90の下部を下側から支持することができるので、子宮脱又は子宮下垂の予防または治療を行うことができる。このとき、樹脂リング10の内側には、子宮膣部94が嵌まり込んだ状態になることにより、樹脂リング10は、より安定して膣内に保持される。なお、樹脂リング10は、膣91の上端の周囲に位置する臓器(例えば膀胱98、直腸99)に対しても刺激を与えうる。そのため、リングペッサリー1は、子宮脱又は子宮下垂の治療と共に、膀胱脱、頻尿、便秘等を抑制する効果も生じ得る。また、ペッサリーの早期の使用により(例えば産後しばらくして)子宮下垂の早い段階で、使用することで、子宮下垂、子宮脱になることを防ぎ、腟の回復を促すことができる。 As shown in FIG. 2, the ring pessary 1 is placed at the upper end of the vagina 91 when the ring pessary 1 is used to treat uterine prolapse or uterine droop. At this time, the resin ring 10 (particularly the outer surface 13) of the ring pessary 1 is held at the upper end of the vagina 91 by the surrounding soft tissue (vagina wall 95), and the upper surface 11 of the resin ring 10 is the uppermost end of the vagina 91. It comes into contact with the vaginal lid 93 (upward concave inner wall surrounding the uterine vagina part 94). Thereby, since the ring pessary 1 can support the lower part of the uterus 90 from the lower side, it can prevent or treat uterine prolapse or uterine droop. At this time, since the uterine vagina part 94 is fitted inside the resin ring 10, the resin ring 10 is more stably held in the vagina. The resin ring 10 can also stimulate an organ (for example, the bladder 98 and the rectum 99) located around the upper end of the vagina 91. Therefore, the ring pessary 1 can also have an effect of suppressing bladder prolapse, frequent urination, constipation, and the like along with treatment of uterine prolapse or uterine droop. In addition, by using pessaries early (for example, after birth, at an early stage of uterine drooping), it is possible to prevent uterine drooping and uterine prolapse and to promote recovery of wrinkles.
 リングペッサリー1は、矢印X方向(図2(a))から経膣的に膣91の上端に挿入される。このとき、図3に示すように、樹脂リング10を直径方向両側から荷重F、Fにより圧縮して、樹脂リング10’のような細長い形状にすることにより、リングペッサリー1を膣91に挿入するのが極めて容易になる。成人女性の膣の直径は約2cm~3cmであることから、樹脂リング10を2cmまで変形させることにより、樹脂リング10を膣91内に挿入する際の抵抗を著しく低下させることができる。つまり、樹脂リング10の外直径OD=5~9cmを2cmまで変形させてから膣91内に挿入すれば、リングペッサリー1の挿入が極めて容易になる。よって、若年の未経産婦であっても、リングペッサリー1を容易に挿入することができる。 The ring pessary 1 is inserted into the upper end of the vagina 91 transvaginally from the direction of arrow X (FIG. 2A). At this time, as shown in FIG. 3, the resin ring 10 is compressed from the both sides in the diametrical direction with loads F 1 and F 2 so as to have an elongated shape like the resin ring 10 ′. It becomes very easy to insert. Since the diameter of the vagina of an adult woman is about 2 cm to 3 cm, the resistance when the resin ring 10 is inserted into the vagina 91 can be significantly reduced by deforming the resin ring 10 to 2 cm. That is, if the outer diameter OD = 5 to 9 cm of the resin ring 10 is deformed to 2 cm and then inserted into the vagina 91, the ring pessary 1 can be inserted very easily. Therefore, the ring pessary 1 can be easily inserted even by a young mother.
 樹脂リング10の外直径OD=5~9cmを外寸法DD=2cmまで圧縮するために必要な荷重(これを本明細書では「圧縮荷重」と称する)は、2~10Nとすることができる。2~10Nという圧縮荷重は、女性の指先で十分に負荷することのできる小さい荷重である。そのため、女性患者は、指先で樹脂リング10を変形させることが可能である。つまり、リングペッサリー1を挿入する際、患者は患者自身の指先で樹脂リング10を2cmまで圧縮してから、膣内に挿入することができる。また、リングペッサリー1を膣内から取り出す時は、患者自身が膣内に指先を挿入して樹脂リング10をはさみ、樹脂リング10の外寸法DDを2cmまで圧縮してから引き抜くことができる。このように、リングペッサリー1の挿入と取出しの際に、樹脂リング10を十分に細長くできるので、患者は強い痛みを伴うことなしに、リングペッサリー1を挿入すること及び取り出すことができる。 The load necessary for compressing the outer diameter OD = 5-9 cm of the resin ring 10 to the outer dimension DD = 2 cm (this is referred to as “compressive load” in this specification) can be 2-10 N. A compressive load of 2 to 10 N is a small load that can be sufficiently applied by a female fingertip. Therefore, the female patient can deform the resin ring 10 with the fingertip. That is, when inserting the ring pessary 1, the patient can insert the resin ring 10 into the vagina after compressing the resin ring 10 to 2 cm with the patient's own fingertip. Further, when the ring pessary 1 is taken out from the vagina, the patient himself / herself can insert the fingertip into the vagina to sandwich the resin ring 10, compress the outer dimension DD of the resin ring 10 to 2 cm, and then pull it out. Thus, since the resin ring 10 can be sufficiently elongated when the ring pessary 1 is inserted and removed, the patient can insert and remove the ring pessary 1 without causing severe pain.
 なお、本明細書において「樹脂リング10の外直径OD」とは、(変形前の円形の)樹脂リング10を上面視したときの「樹脂リング10の外側面13の直径」のことである。言い換えれば、変形前の樹脂リング10を上面視して、樹脂リング10の外側面13上の第1の点から、円の中心を通って反対側に位置する外側面13上の第2の点までの距離である。 In the present specification, “the outer diameter OD of the resin ring 10” means “the diameter of the outer surface 13 of the resin ring 10” when the resin ring 10 (circular shape before deformation) is viewed from above. In other words, when the resin ring 10 before deformation is viewed from above, the second point on the outer surface 13 located on the opposite side through the center of the circle from the first point on the outer surface 13 of the resin ring 10. It is the distance to.
 そして、本明細書において「樹脂リング10の外寸法DD」とは、変形後又は除荷後の樹脂リング10における最小外寸法をいう。変形後の樹脂リング10を上面視したときに、外直径ODを測定した2点間(第1の点と第2の点との間)の距離(=広義の外寸法)は、様々な値を取り得る。そのうち最も小さい値を、本願における「外寸法DD」とした。
 なお、樹脂リング10を変形させた後に除荷したとき、樹脂リング10が完全に復元した場合(元の樹脂リング10と同じ円形に戻った場合)、変形して復元した後の樹脂リング10の「外寸法DD」は、変形前の樹脂リング10の「外直径OD」と一致することになる。
In the present specification, “the outer dimension DD of the resin ring 10” refers to the minimum outer dimension of the resin ring 10 after deformation or unloading. When the deformed resin ring 10 is viewed from above, the distance between the two points (between the first point and the second point) at which the outer diameter OD is measured (= the outer dimension in a broad sense) has various values. Can take. The smallest value among them was defined as “outside dimension DD” in the present application.
In addition, when the resin ring 10 is completely unrestored when the resin ring 10 is unloaded after being deformed (when the resin ring 10 returns to the same circle as the original resin ring 10), the resin ring 10 after being deformed and restored is restored. The “outer dimension DD” matches the “outer diameter OD” of the resin ring 10 before deformation.
 ところで、従来は、子宮脱又は子宮下垂の治療の際に子宮の下側をしっかり支えるためには硬質のリングペッサリーを使用する必要がある、と考えられていた。しかしながら、本願発明者は、樹脂リング10の圧縮荷重が2~10Nであれば、十分に子宮を支えることができるため、子宮脱又は子宮下垂の治療効果が得られることを見いだした。すなわち、本発明のリングペッサリー1は、(これまで子宮脱又は子宮下垂の治療に使用できないと考えられていた)軟質で変形しやすい樹脂リング10を使用することにより、十分に子宮脱又は子宮下垂の治療が可能で、且つ装着及び取出しが容易という従来にない新規なリングペッサリー1である。
 なお、樹脂リング10の圧縮荷重が2~8Nであると好ましく、3~5Nであるとより好ましい。これにより、体内に挿入しやすく、子宮脱又は子宮下垂の治療に好適なリングペッサリー1を提供することができる。
Conventionally, it has been considered that it is necessary to use a hard ring pessary to firmly support the lower side of the uterus in the treatment of uterine prolapse or uterine droop. However, the inventor of the present application has found that when the compressive load of the resin ring 10 is 2 to 10 N, the uterus can be sufficiently supported, so that a therapeutic effect on uterine prolapse or uterus is obtained. That is, the ring pessary 1 of the present invention can be sufficiently removed from the uterus or the uterus by using the soft and easily deformable resin ring 10 (previously considered to be unusable for the treatment of uterine prolapse or uterus). This is a novel ring pessary 1 that is easy to mount and take out.
The compressive load of the resin ring 10 is preferably 2 to 8N, and more preferably 3 to 5N. Thereby, the ring pessary 1 which can be easily inserted into the body and is suitable for treatment of uterine prolapse or uterine drooping can be provided.
 リングペッサリー1に用いられる樹脂リング10は、膣内に挿入して荷重F、Fを除荷した後、比較的短時間である程度円形に戻ることが要求される。もし、樹脂リング10がほぼ円形に戻らなければ、樹脂リング10は膣円蓋93の下にうまく嵌まり込むことができず、子宮を下から支えることができない。また、樹脂リング10が細長く変形したままの状態であると、リングペッサリー1は、重力によって膣91内を下向きに通り抜けて、体外に抜け落ちやすくなる。そのため、樹脂リング10には、適度な復元力(樹脂リング10を変形させるための荷重を取り除いた後に、元の形状に戻ろうとする力)が必要となる。具体的には、除荷後30秒における樹脂リング10の外寸法DDが、樹脂リング10の外直径ODの70%以上となるような復元力を有しているのが望ましい。ここで、「復元率=DD/OD×100(%)」と定義すれば、除荷後30秒の復元率が70%以上の樹脂リング10が望ましいといえる。 The resin ring 10 used for the ring pessary 1 is required to return to a circular shape to some extent in a relatively short time after being inserted into the vagina and unloading the loads F 1 and F 2 . If the resin ring 10 does not return to a substantially circular shape, the resin ring 10 cannot fit well under the vaginal lid 93 and cannot support the uterus from below. Further, when the resin ring 10 is in the state of being elongated and deformed, the ring pessary 1 easily passes through the vagina 91 downward due to gravity and falls off the body. Therefore, the resin ring 10 needs an appropriate restoring force (a force for returning to the original shape after removing the load for deforming the resin ring 10). Specifically, it is desirable that the resin DD 10 has a restoring force such that the outer dimension DD of the resin ring 10 at 30 seconds after unloading is 70% or more of the outer diameter OD of the resin ring 10. Here, if it is defined as “restoration rate = DD / OD × 100 (%)”, it can be said that the resin ring 10 having a restoration rate of 70% or more 30 seconds after unloading is desirable.
 樹脂リング10は、完全な円形(樹脂リング10の外寸法DD=樹脂リング10の外直径OD)のとき、樹脂リング10は、膣91上端の所定位置(膣円蓋93の下の空間)にぴったり嵌まって、その位置に保持される。しかしながら、多少の変形であれば、所定位置に問題なく保持できる。例えば、復元率70%以上であれば、膣91上端の所定位置に保持することができる。 When the resin ring 10 is completely circular (the outer dimension DD of the resin ring 10 = the outer diameter OD of the resin ring 10), the resin ring 10 is placed at a predetermined position at the upper end of the vagina 91 (the space below the vaginal lid 93). Fits tightly and holds in place. However, if it is slightly deformed, it can be held at a predetermined position without any problem. For example, when the restoration rate is 70% or more, the upper end of the vagina 91 can be held at a predetermined position.
 復元率の規定において、「除荷後30秒」とは、患者がリングペッサリー1を変形させて膣91内に挿入した後に指先を離してから、30秒後のことを想定している。除荷後30秒あれば、膣91内に挿入したリングペッサリー1を膣91上端の所定位置(膣円蓋93の下の空間)に位置決めすることができる。よって、除荷後30秒後に、樹脂リング10が所定位置に位置決めされた時点で、樹脂リング10が外直径ODの70%以上に復元していれば、樹脂リング10はそのまま所定位置に保持することができる。 In the regulation of the restoration rate, “30 seconds after unloading” is assumed to be 30 seconds after the patient releases the fingertip after the ring pessary 1 is deformed and inserted into the vagina 91. If there are 30 seconds after the unloading, the ring pessary 1 inserted into the vagina 91 can be positioned at a predetermined position at the upper end of the vagina 91 (a space below the vaginal lid 93). Therefore, if the resin ring 10 is restored to 70% or more of the outer diameter OD when the resin ring 10 is positioned at a predetermined position 30 seconds after unloading, the resin ring 10 is held at the predetermined position as it is. be able to.
 すなわち、除荷後30秒の復元率70%以上の樹脂リング10であれば、除荷後30秒以内に樹脂リング10が膣円蓋93下の所定位置に位置決めされ、そのままその位置に保持することができるので、リングペッサリー1の装着が容易になる。特に、除荷後30秒の復元率が80%以上であるのが好ましく、90%以上であるのが特に好ましい。 That is, if the resin ring 10 has a recovery rate of 70% or more 30 seconds after unloading, the resin ring 10 is positioned at a predetermined position under the vaginal lid 93 within 30 seconds after unloading and is held in that position. Therefore, the ring pessary 1 can be easily attached. In particular, the restoration rate after 30 seconds after unloading is preferably 80% or more, and particularly preferably 90% or more.
 再び図1を参照すると、リングペッサリー1は、樹脂リング10の下面12側の開口16を覆う軟質フィルム20を備えていてもよい。軟質フィルム20を備えたリングペッサリー1を膣91上端に挿入すると、樹脂リング10の内側に嵌まり込んだ子宮膣部94の下側は、軟質フィルム20によって覆われる(図2(a)、(b)参照)。このとき、樹脂リング10の下面12が軟質フィルム20で覆われていると、軟質フィルム20によって帯下を受容することができる。特に、リングペッサリー1による治療を受けている患者によっては帯下の増加がみられる場合があるが、軟質フィルム20付きのリングペッサリー1を使用することにより、軟質フィルム20によって帯下を受容することができる。これにより、帯下による不快感を軽減することができる。また、生理中に使用する事も可能で、子宮脱及び子宮下垂を予防する生理用品としての用途も可能である。 Referring to FIG. 1 again, the ring pessary 1 may include a soft film 20 that covers the opening 16 on the lower surface 12 side of the resin ring 10. When the ring pessary 1 with the soft film 20 is inserted into the upper end of the vagina 91, the lower side of the uterine vagina part 94 fitted inside the resin ring 10 is covered with the soft film 20 (FIG. 2 (a), ( b)). At this time, if the lower surface 12 of the resin ring 10 is covered with the soft film 20, the lower part can be received by the soft film 20. In particular, depending on the patient who is being treated with the ring pessary 1, there may be an increase in the lower band, but by using the ring pessary 1 with the soft film 20, the lower film is received by the soft film 20. Can do. Thereby, the discomfort by the belt can be reduced. It can also be used during menstruation, and can also be used as a sanitary product for preventing uterine prolapse and uterine drooping.
 また、リングペッサリー1の使用により膣炎等を起こしやすい患者の場合、膣炎の治療のため又は膣炎予防のために、リングペッサリー1と共に膣錠を併用する場合がある。このとき、膣上端に膣錠を入れた後に、軟質フィルム20を備えたリングペッサリー1を配置すれば、膣錠及び膣内で溶解した膣錠溶解物を軟質フィルム20によって膣上端に保持することができるので、投薬効果を高められると期待できる。
 軟質フィルム20は、樹脂リング10の下面を平坦に覆う膜から形成してもよいが、図1等に示すように下向きに膨らんだ膜にすると、液体(帯下や膣錠溶解物)を受容しやすくなるので好ましい。
In addition, in the case of a patient who tends to cause vaginitis or the like due to the use of ring pessary 1, vaginal tablets may be used in combination with ring pessary 1 for the treatment of vaginitis or for the prevention of vaginitis. At this time, if the ring pessary 1 having the soft film 20 is placed after putting the vaginal tablet in the upper end of the vagina, the vaginal tablet and the dissolved vaginal tablet dissolved in the vagina are held on the upper end of the vagina by the soft film 20. Can be expected to increase the effect of medication.
The soft film 20 may be formed from a film that covers the lower surface of the resin ring 10 flatly. However, when the film is swollen downward as shown in FIG. Since it becomes easy to do, it is preferable.
 軟質フィルム20は、樹脂リング10の下面12側に接着、融着等によって固定してもよい。また、樹脂リング10を芯材として、その周りに軟質フィルム20の端部等を巻き付けることにより、軟質フィルム20を樹脂リング10に固定してもよい。 The soft film 20 may be fixed to the lower surface 12 side of the resin ring 10 by adhesion, fusion, or the like. Moreover, you may fix the soft film 20 to the resin ring 10 by winding the edge part etc. of the soft film 20 around the resin ring 10 as a core material.
 なお、軟質フィルム20を備えたリングペッサリー1の場合、樹脂リング10の圧縮荷重および復元率は、以下の理由から、軟質フィルム20を備えた状態で測定した樹脂リング10の圧縮荷重および復元率であるのが好ましい。
 樹脂リング10の圧縮荷重は、使用されるリングペッサリー1を体内に挿入しやすくするために規定されている。樹脂リング10の復元率は、使用されるリングペッサリー1を体内に挿入した後に、所定位置に確実に保持されるように規定されている。つまり、実際に使用されるリングペッサリー1において、樹脂リング10が所定の圧縮荷重と所定の復元率を有している必要がある。そのため、軟質フィルム20を備えたリングペッサリー1においては、軟質フィルム20を備えた状態の樹脂リング10が、本発明において規定された圧縮荷重および復元率を有している必要がある。
 なお、後述するように、本実施の形態に係るリングペッサリー1は、薬剤保持部、紐取付け部、突起部等の様々な追加の構成を備えることができる。その場合には、樹脂リング10の圧縮荷重および復元率は、それらの追加の構成を備えた状態で測定された樹脂リング10の圧縮荷重および復元率のことである。
In the case of the ring pessary 1 provided with the soft film 20, the compression load and the restoration rate of the resin ring 10 are the compression load and the restoration rate of the resin ring 10 measured with the soft film 20 for the following reason. Preferably there is.
The compressive load of the resin ring 10 is defined so that the ring pessary 1 to be used can be easily inserted into the body. The restoration rate of the resin ring 10 is defined so that the ring pessary 1 to be used is securely held at a predetermined position after being inserted into the body. That is, in the ring pessary 1 actually used, the resin ring 10 needs to have a predetermined compression load and a predetermined restoration rate. Therefore, in the ring pessary 1 provided with the soft film 20, the resin ring 10 provided with the soft film 20 needs to have the compression load and the restoration rate defined in the present invention.
As will be described later, the ring pessary 1 according to the present embodiment can have various additional configurations such as a medicine holding part, a string attaching part, and a protruding part. In that case, the compressive load and the restoration rate of the resin ring 10 are the compressive load and the restoration rate of the resin ring 10 measured in a state having these additional configurations.
 図4(a)~(b)と図5(a)~(b)は、様々な断面形状の樹脂リング10を備えたリングペッサリー1を示している。なお、これらの断面は、樹脂リング10の直径方向に伸びる線(具体的には図1(b)のA-A線)における断面図である。
 図4(a)のリングペッサリー1は、断面形状が長方形の樹脂リング10を備えている。このような断面形状の樹脂リング10の特徴は、平坦な外側面13を備えている点である。このリングペッサリー1を膣内に配置すると、平坦な外側面13が膣壁95に接触することにより、リングペッサリー1を膣上端の所定位置に安定して保持することができる。よって、樹脂リング10の圧縮荷重が小さい場合(つまり、変形しやすい樹脂リング10の場合)でも、体外に抜け落ちにくいリングペッサリー1を得ることができる。
FIGS. 4 (a) to 4 (b) and FIGS. 5 (a) to 5 (b) show a ring pessary 1 including resin rings 10 having various cross-sectional shapes. These cross sections are cross sectional views taken along a line extending in the diameter direction of the resin ring 10 (specifically, a line AA in FIG. 1B).
The ring pessary 1 in FIG. 4A includes a resin ring 10 having a rectangular cross-sectional shape. A feature of the resin ring 10 having such a cross-sectional shape is that a flat outer surface 13 is provided. When the ring pessary 1 is disposed in the vagina, the flat outer surface 13 contacts the vagina wall 95, so that the ring pessary 1 can be stably held at a predetermined position on the upper end of the vagina. Therefore, even when the compressive load of the resin ring 10 is small (that is, in the case of the resin ring 10 that is easily deformed), the ring pessary 1 that does not easily fall out of the body can be obtained.
 また、患者がリングペッサリー1を取り出す場合、膣91内に挿入した2本以上の指先で樹脂リング10の外側面13をつまんで、体外に引っ張り出す。このとき、樹脂リング10の外側面13が平坦であると、断面形状が円形の樹脂リング10(図4(d))に比べて、指先で外側面13をつまむときに指先が滑りにくい。よって、患者自身によるリングペッサリー1の取り出しが容易になる。 Further, when the patient takes out the ring pessary 1, the outer surface 13 of the resin ring 10 is pinched with two or more fingertips inserted into the vagina 91 and pulled out of the body. At this time, if the outer surface 13 of the resin ring 10 is flat, the fingertip is less likely to slip when the outer surface 13 is pinched with the fingertip, as compared to the resin ring 10 having a circular cross-sectional shape (FIG. 4D). Therefore, the patient can easily take out the ring pessary 1.
 特に、樹脂リング10の断面形状において、樹脂リング10の外側面13及び内側面14を長辺とし、上面11及び下面12を短辺とするような長方形であるのが好ましい。言い換えれば、図1及び図4(a)に示すように、樹脂リング10の厚さT(直径方向における寸法)よりも、幅W(z方向の寸法)が大きい樹脂リング10が好ましい。これにより、樹脂リング10の外側面13の面積を広くすることができるので、リングペッサリー1の抜け落ち抑制効果を向上することができる。また、患者自身によるリングペッサリー1の取り出しもさらに容易になる。 Particularly, in the cross-sectional shape of the resin ring 10, it is preferable that the outer side surface 13 and the inner side surface 14 of the resin ring 10 have long sides and the upper surface 11 and the lower surface 12 have short sides. In other words, as shown in FIGS. 1 and 4A, the resin ring 10 having a width W (dimension in the z direction) larger than the thickness T (dimension in the diameter direction) of the resin ring 10 is preferable. Thereby, since the area of the outer side surface 13 of the resin ring 10 can be enlarged, the drop-off prevention effect of the ring pessary 1 can be improved. In addition, the patient can easily take out the ring pessary 1.
 図4(b)のリングペッサリー1は、図4(a)のリングペッサリー1を変形したものである。具体的には、外側面13と上面11との間のエッジ(外側上エッジ)EDと、外側面13と下面12との間のエッジ(外側下エッジ)EDとを、曲面で面取りしている。外側上エッジED及び外側下エッジEDは、リングペッサリー1を膣内に配置したときに膣壁95に接触するので(図2(b))、それらのエッジED、EDを面取りすることにより、エッジED、EDによる膣壁95の損傷を抑制することができる。 The ring pessary 1 in FIG. 4B is a modification of the ring pessary 1 in FIG. Specifically, an edge (outer upper edge) ED 1 between the outer surface 13 and the upper surface 11 and an edge (outer lower edge) ED 2 between the outer surface 13 and the lower surface 12 are chamfered with a curved surface. ing. Since the outer upper edge ED 1 and the outer lower edge ED 2 contact the vagina wall 95 when the ring pessary 1 is placed in the vagina (FIG. 2B), the edges ED 1 and ED 2 are chamfered. Thus, damage to the vagina wall 95 due to the edges ED 1 and ED 2 can be suppressed.
 内側面14と上面11との間のエッジ(内側上エッジED)も、曲面で面取りするのが好ましい。内側上エッジEDは、リングペッサリー1を膣内に配置したときに膣円蓋93に接触しうるので(図2(b))、内側上エッジEDを面取りすることにより、内側上エッジEDによる膣円蓋93の損傷を抑制することができる。
 内側面14と下面12との間のエッジ(内側下エッジED)は、他のエッジに比べると膣91内の軟組織に接触しにくいため、内側下エッジEDによる膣91内の軟組織への損傷を起こしにくい。しかしながら、膣91内の軟組織はデリケートなので、内側下エッジEDも曲面で面取りして、軟組織に損傷を与えるリスクを確実に回避するのが好ましい。
The edge between the inner side surface 14 and the upper surface 11 (inner upper edge ED 3 ) is also preferably chamfered with a curved surface. Since the inner upper edge ED 3 can come into contact with the vaginal lid 93 when the ring pessary 1 is placed in the vagina (FIG. 2B), the inner upper edge ED 3 is chamfered so that the inner upper edge ED 3 is chamfered. 3 can prevent the vaginal lid 93 from being damaged.
Since the edge between the inner surface 14 and the lower surface 12 (inner lower edge ED 4 ) is less likely to contact the soft tissue in the vagina 91 than the other edges, the inner lower edge ED 4 is applied to the soft tissue in the vagina 91. Less likely to cause damage. However, since the soft tissue in the vagina 91 is delicate, it is preferable to chamfer the inner lower edge ED 4 with a curved surface to reliably avoid the risk of damaging the soft tissue.
 図5(a)のリングペッサリー1は、図4(b)のリングペッサリー1において、樹脂リング10のエッジED~EDが完全になくなるように変形したものである。図5(a)のリングペッサリー1の特徴は、樹脂リング10の断面形状が、直線状の外側面13と、凸状曲線の上面11とを含んでいることである。外側面13が直線状(つまり、外側面13が平坦)であるので、図4(a)のリングペッサリー1と同様に、リングペッサリー1の抜け落ち抑制効果と、患者自身によるリングペッサリー1の取り出し容易性の効果が得られる。そして、樹脂リング10の上面11を(膣円蓋93の形状と類似の)凸状曲面にすることにより、子宮脱又は子宮下垂の治療のために上面11で膣円蓋93を下から支える際に、膣円蓋93に無理な力がかかるのを回避できる。これにより、膣円蓋93の損傷を抑制すると共に、膣炎を抑制する効果も期待できる。
 なお、リングペッサリー1は、従来と同様に、図5(b)のような断面形状が円形の樹脂リング10を備えてもよい。
The ring pessary 1 in FIG. 5A is a modification of the ring pessary 1 in FIG. 4B so that the edges ED 1 to ED 4 of the resin ring 10 are completely eliminated. The characteristic of the ring pessary 1 in FIG. 5A is that the cross-sectional shape of the resin ring 10 includes a linear outer surface 13 and an upper surface 11 having a convex curve. Since the outer side surface 13 is straight (that is, the outer side surface 13 is flat), the effect of preventing the ring pessary 1 from falling off and the patient's own removal of the ring pessary 1 are easy as in the ring pessary 1 of FIG. Sexual effect is obtained. When the upper surface 11 of the resin ring 10 is a convex curved surface (similar to the shape of the vaginal lid 93), the upper surface 11 supports the vaginal cap 93 from below for the treatment of uterine prolapse or uterine drooping. In addition, it is possible to avoid applying excessive force to the vaginal lid 93. Thereby, while suppressing the damage of the vaginal lid 93, the effect of suppressing vaginitis can also be expected.
The ring pessary 1 may include a resin ring 10 having a circular cross-sectional shape as shown in FIG.
 図6(a)~(b)は、様々な形状を有する軟質フィルム20を備えたリングペッサリー1を示している。図6(a)のリングペッサリー1は、軟質フィルム20の中央部分が下方向(-z方向)に伸びた形状になっている。図6(b)のリングペッサリー1は、軟質フィルム20の全体が、y方向において中心位置からずれた点を中心として下方向に引っ張ったような形状になっている。このように、軟質フィルム20が下方向に伸びていると、その伸びた部分を指先で引っ張ることにより、リングペッサリー1を膣内から比較的容易に取り出すことができる。 6 (a) to 6 (b) show the ring pessary 1 provided with the soft film 20 having various shapes. The ring pessary 1 in FIG. 6A has a shape in which the central portion of the soft film 20 extends downward (−z direction). The ring pessary 1 in FIG. 6B has a shape in which the entire soft film 20 is pulled downward about a point that is shifted from the center position in the y direction. Thus, when the flexible film 20 is extended downward, the ring pessary 1 can be taken out from the vagina relatively easily by pulling the extended portion with a fingertip.
 図7(a)~(b)、図8(a)~(c)に示すように、樹脂リング10は、薬剤を保持するための薬剤保持部18を備えることができる。リングペッサリー1による治療では、リングペッサリー1が接触する膣上端近傍において膣炎を起こしやすいことが知られている。膣炎予防のために、又は膣炎発症後の治療のために、経膣的に投薬される薬剤(例えばエストリオール)が利用されている。そのような薬剤を、樹脂リング10の薬剤保持部18に保持した状態でリングペッサリー1を膣内に挿入することにより、子宮脱又は子宮下垂の治療と、薬剤の投薬とを同時に行うことができる。 7 (a) to (b) and FIGS. 8 (a) to (c), the resin ring 10 may include a medicine holding portion 18 for holding medicine. It is known that treatment with the ring pessary 1 is likely to cause vaginitis near the upper end of the vagina where the ring pessary 1 comes into contact. Drugs (eg, estriol) that are administered vaginally are used for the prevention of vaginitis or for the treatment after the onset of vaginitis. By inserting the ring pessary 1 into the vagina while holding such a drug in the drug holding part 18 of the resin ring 10, treatment of uterine prolapse or uterus and drug administration can be performed simultaneously. .
 特に、本発明のリングペッサリー1は、患者自身が毎日着脱することができるので、投薬が必要な日は、薬剤保持部18に薬剤を入れてからリングペッサリー1を使用し、投薬が不要な日は、薬剤を入れずにリングペッサリー1を使用することができる。このように投薬を制御できるので、不要な投薬を回避することができる。
 薬剤保持部18に入れる薬剤としては、錠剤、粉末状、ゼリー状等の様々な形態のものを使用できる。錠剤の薬剤は、患者が薬剤保持部18に入れるのが容易である。一方、粉末状やゼリー状の薬剤は、薬剤保持部18に入れる量を調整しやすい。
In particular, the ring pessary 1 of the present invention can be attached and detached by the patient every day. Therefore, on the day when medication is required, the drug is placed in the drug holding unit 18 and then the ring pessary 1 is used, and no medication is required. Can use the ring pessary 1 without a drug. Since medication can be controlled in this way, unnecessary medication can be avoided.
As a medicine to be put in the medicine holding part 18, various forms such as tablets, powders, jellys and the like can be used. It is easy for the patient to put the medicine in the tablet into the medicine holder 18. On the other hand, the amount of the powdery or jelly-like medicine can be easily adjusted in the medicine holding part 18.
 図7(a)~(b)は、樹脂リング10の内側面14に設けられた凹状の薬剤保持部18(181a、181b)を示している。薬剤保持部18を内側面14に形成すると、リングペッサリー1を膣内に配置したときに、樹脂リング10の内側に嵌まり込んだ子宮膣部94(図2(a)、(b))に対して薬剤を近接して配置することができるので、子宮膣部94への治療効果を高めることができる。 7 (a) to 7 (b) show concave drug holding portions 18 (181a, 181b) provided on the inner side surface 14 of the resin ring 10. FIG. When the medicine holding portion 18 is formed on the inner side surface 14, when the ring pessary 1 is placed in the vagina, the uterine vagina portion 94 (FIGS. 2A and 2B) fitted inside the resin ring 10 is provided. On the other hand, since the drug can be disposed in proximity, the therapeutic effect on the uterine vagina part 94 can be enhanced.
 図7(a)~(b)に示す薬剤保持部181aは、正面視において楕円形状になっているが、これに限定されず、薬剤の入れやすさ、錠剤の剤型等に合わせて円形、多角形(三角形、四角形、五角形等)等にすることができる。また、薬剤保持部181aは、図示したような一定の深さの凹部(つまり、底面が平面状の凹部)に限定されず、深さが変化する凹部にすることもできる。例えば、錠剤の剤型が丸みを帯びている場合、それに合わせて丸みを帯びた底面を有する凹部にすることもできる。 The drug holding part 181a shown in FIGS. 7 (a) to 7 (b) has an elliptical shape when viewed from the front, but is not limited to this, and is circular according to the ease of putting the drug, the dosage form of the tablet, etc. It can be a polygon (triangle, quadrangle, pentagon, etc.). Further, the medicine holding part 181a is not limited to a concave part having a constant depth as shown in the figure (that is, a concave part having a flat bottom surface), and may be a concave part whose depth changes. For example, when the tablet dosage form is rounded, a concave portion having a rounded bottom surface can be formed accordingly.
 図7(b)には、薬剤保持部181aの変形例として、錠剤の脱落抑制を目的とした薬剤保持部181bも示されている。薬剤保持部181bは、内側面14側に開いた開口部の寸法181xを錠剤の外寸法より僅かに小さくし、薬剤保持部181bの最大寸法181yを錠剤の外寸法より大きくしている。開口部を押し広げて錠剤を薬剤保持部181b内に収納することにより、錠剤が薬剤保持部181bから脱落するのを抑制することができる。 FIG. 7 (b) also shows a drug holding unit 181b for the purpose of suppressing tablet dropout as a modified example of the drug holding unit 181a. The medicine holding part 181b has a dimension 181x of an opening opened on the inner surface 14 side slightly smaller than the outer dimension of the tablet, and a maximum dimension 181y of the medicine holding part 181b larger than the outer dimension of the tablet. By expanding the opening and storing the tablet in the medicine holding part 181b, it is possible to prevent the tablet from dropping from the medicine holding part 181b.
 薬剤保持部18を樹脂リング10の内側面14に設ける場合、軟質フィルム20を備えているのが好ましい。薬剤保持部18に薬剤を入れる場合、粉末状やゼリー状の薬剤は薬剤保持部18からこぼれ出る恐れがあるが、軟質フィルム20を備えていれば、薬剤を軟質フィルム20で受けることができる。また、リングペッサリー1を膣内に設置した後に、薬剤が体液で溶解したときに、溶解した薬剤を軟質フィルム20で受けることにより、体外に流れ出るのを抑制することができる。なお、軟質フィルム20に溜まった薬剤は、膣91の上端に保持されることになるので(図2(b))、膣炎の防止又は膣炎は症後の治療の効果を高めることができる。 When providing the medicine holding part 18 on the inner side surface 14 of the resin ring 10, it is preferable to provide a soft film 20. When a drug is put in the drug holding unit 18, powdered or jelly-like drugs may spill out from the drug holding unit 18, but if the soft film 20 is provided, the drug can be received by the soft film 20. Moreover, after the ring pessary 1 is placed in the vagina, when the drug is dissolved in the body fluid, the dissolved drug is received by the soft film 20 so that it can be prevented from flowing out of the body. In addition, since the chemical | medical agent collected on the soft film 20 will be hold | maintained at the upper end of the vagina 91 (FIG.2 (b)), the prevention of vaginitis or the vaginitis can heighten the effect of the treatment after a symptom. .
 図8(a)は、樹脂リング10の外側面13に設けられた凹状の薬剤保持部18(182a、182b)を示している。薬剤保持部18を外側面14に形成すると、リングペッサリー1を膣内に配置したときに、樹脂リング10の外側面13が接触する膣壁95(図2(b))に対して薬剤を近接して配置することができるので、膣壁95への治療効果を高めることができる。
 なお、図8(a)に示された薬剤保持部182aを構成する凹部の形態(例えば、正面視の形状、凹部の深さ等)については、図7(a)~(b)に示された薬剤保持部181aと同様である。
FIG. 8A shows concave drug holding portions 18 (182 a and 182 b) provided on the outer side surface 13 of the resin ring 10. When the medicine holding portion 18 is formed on the outer surface 14, the medicine is brought close to the vagina wall 95 (FIG. 2B) with which the outer surface 13 of the resin ring 10 contacts when the ring pessary 1 is disposed in the vagina. Therefore, the therapeutic effect on the vaginal wall 95 can be enhanced.
Note that the shape of the concave portion (for example, the shape of the front view, the depth of the concave portion, etc.) constituting the medicine holding portion 182a shown in FIG. 8A is shown in FIGS. 7A to 7B. This is the same as the medicine holding unit 181a.
 図8(a)には、薬剤保持部182aの変形例として、錠剤の脱落抑制を目的とした薬剤保持部182bも示されている。薬剤保持部182bは、外側面13側に開いた開口部の寸法182xを錠剤の外寸法より僅かに小さくし、薬剤保持部182bの最大寸法181yを錠剤の外寸法より大きくしている。開口部を押し広げて錠剤を薬剤保持部182b内に収納することにより、錠剤が薬剤保持部182bから脱落するのを抑制することができる。 FIG. 8 (a) also shows a drug holding part 182b for the purpose of suppressing tablet dropout as a modified example of the drug holding part 182a. The medicine holding part 182b has a dimension 182x of an opening opened on the outer surface 13 side slightly smaller than the outer dimension of the tablet, and a maximum dimension 181y of the medicine holding part 182b larger than the outer dimension of the tablet. By expanding the opening and storing the tablet in the medicine holding part 182b, it is possible to suppress the tablet from dropping off from the medicine holding part 182b.
 図8(b)は、樹脂リング10の内側面14から外側面13に貫通する貫通孔から成る薬剤保持部18(183a、183b)を示している。薬剤保持部18は内側面14と外側面13との両方に連通しているので、図7(a)~(b)に示す薬剤保持部181aの効果と、図8(a)に示す薬剤保持部182aの効果とを有している。すなわち、図8(b)に示す薬剤保持部18は内側面14に連通しているので、樹脂リング10の内側に嵌まり込む子宮膣部94(図2(b))に対する治療効果を高めることができる。さらに、図8(b)に示す薬剤保持部18は外側面13に連通しているので、膣壁95(図2(b))に対する治療効果を高めることもできる。 FIG. 8 (b) shows a drug holding portion 18 (183 a, 183 b) composed of a through hole penetrating from the inner side surface 14 to the outer side surface 13 of the resin ring 10. Since the medicine holding part 18 communicates with both the inner side surface 14 and the outer side face 13, the effect of the medicine holding part 181a shown in FIGS. 7A and 7B and the medicine holding part shown in FIG. Part 182a. That is, since the medicine holding part 18 shown in FIG. 8B communicates with the inner side surface 14, the therapeutic effect on the uterine vagina part 94 (FIG. 2B) fitted inside the resin ring 10 is enhanced. Can do. Furthermore, since the medicine holding portion 18 shown in FIG. 8B communicates with the outer side surface 13, the therapeutic effect on the vagina wall 95 (FIG. 2B) can be enhanced.
 図8(b)に示す薬剤保持部183aの正面視における形状は、薬剤の入れやすさ、錠剤の剤型等に合わせて円形、楕円形、多角形(三角形、四角形、五角形等)等にすることができる。
 図8(b)には、薬剤保持部183aの変形例として、錠剤の脱落抑制を目的とした薬剤保持部183bも示されている。薬剤保持部183bは、内側面14側に開いた開口部の寸法183xを錠剤の外寸法より僅かに小さくし、薬剤保持部183bの最大寸法183yを錠剤の外寸法より大きくし、そして外側面13側に開いた開口部の寸法183zを錠剤の外寸法より大幅に小さくしている。内側面14側に開いた開口部を押し広げて錠剤を薬剤保持部183b内に収納することにより、錠剤が薬剤保持部183bからも脱落するのを抑制することができる。
The shape of the medicine holding portion 183a shown in FIG. 8B in a front view is a circle, an ellipse, a polygon (triangle, quadrangle, pentagon, etc.), etc. according to the ease of putting the medicine, the dosage form of the tablet, etc. be able to.
FIG. 8 (b) also shows a drug holding part 183b for the purpose of suppressing tablet dropout as a modified example of the drug holding part 183a. The medicine holding part 183b has a dimension 183x of an opening opened on the inner side surface 14 side slightly smaller than the outer dimension of the tablet, a maximum dimension 183y of the medicine holding part 183b larger than the outer dimension of the tablet, and the outer side face 13 The dimension 183z of the opening that opens to the side is significantly smaller than the outer dimension of the tablet. By opening the opening opened on the inner side surface 14 side and storing the tablet in the medicine holding part 183b, it is possible to prevent the tablet from dropping off from the medicine holding part 183b.
 樹脂リング10の外側面13側から錠剤を入れる場合は、内側面14側の開口部の寸法181xを錠剤の外寸法より大幅に小さくし、外側面13側の開口部寸法183zを錠剤の外寸法より僅かに小さくしてもよい。
 また、内側面14側の開口部の寸法181xと、外側面13側の開口部の寸法183zとを、いずれも錠剤の外寸法より僅かに小さくしてもよく、内側面14側からでも外側面13側からでも錠剤を入れることができる。
When inserting a tablet from the outer surface 13 side of the resin ring 10, the dimension 181x of the opening on the inner surface 14 side is made significantly smaller than the outer dimension of the tablet, and the opening dimension 183z on the outer surface 13 side is set to the outer dimension of the tablet. It may be made slightly smaller.
In addition, both the dimension 181x of the opening on the inner surface 14 side and the dimension 183z of the opening on the outer surface 13 side may be slightly smaller than the outer dimension of the tablet. Tablets can be inserted from the 13th side.
 貫通孔から成る薬剤保持部18の場合、軟質フィルム20を備えているのが好ましい。例えば、薬剤保持部18に外側面14側から薬剤を入れると、粉末状やゼリー状の薬剤は、貫通した薬剤保持部183aを通り抜けて、内側面14側からこぼれ出る恐れがある。しかしながら、軟質フィルム20を備えていれば、薬剤を軟質フィルム20で受けることができる。また、リングペッサリー1を膣内に設置した後に、薬剤が体液で溶解したときに、内側面14側から流れ出る薬剤を軟質フィルム20で受けることにより、体外に流れ出るのを抑制することができる。なお、軟質フィルム20に溜まった薬剤は、膣91の上端に保持されることになるので(図2(b))、膣炎の防止又は膣炎は症後の治療の効果を高めることができる。 In the case of the medicine holding part 18 composed of a through hole, it is preferable that the soft film 20 is provided. For example, when a medicine is put into the medicine holding part 18 from the outer surface 14 side, the powdery or jelly-like medicine may pass through the penetrating medicine holding part 183a and spill out from the inner side face 14 side. However, if the soft film 20 is provided, the drug can be received by the soft film 20. Moreover, after the ring pessary 1 is placed in the vagina, when the drug is dissolved in the body fluid, the drug flowing out from the inner side surface 14 side is received by the soft film 20 so that it can be prevented from flowing out of the body. In addition, since the chemical | medical agent collected on the soft film 20 will be hold | maintained at the upper end of the vagina 91 (FIG.2 (b)), the prevention of vaginitis or the vaginitis can heighten the effect of the treatment after a symptom. .
 図7(a)~(b)、図8(a)では、内側面14又は外側面13に設けた凹部から成る薬剤保持部18が開示されているが、この凹部を円周に沿って長く伸ばして溝部から成る薬剤保持部18とすることもできる。例えば図8(c)には、樹脂リング10の内側面14の円周に沿って設けられた溝状の薬剤保持部18(184)が図示されている。なお、図示しないが、樹脂リング10の外側面13の円周に沿って設けられた溝状の薬剤保持部を設けることもできる。溝状の薬剤保持部18は、凹状の薬剤保持部18に比べて薬剤を入れることのできる容積を広くすることができるので、薬剤の投薬量を多くしたい場合に有利である。また、錠剤の場合には、溝に嵌め込むだけで薬剤を保持できるので、任意の場所に、任意の個数の錠剤を保持することができる。 7 (a) to 7 (b) and FIG. 8 (a) disclose a medicine holding portion 18 composed of a concave portion provided on the inner side surface 14 or the outer side surface 13, but this concave portion is elongated along the circumference. It can also be used as the chemical | medical agent holding part 18 which extends and consists of a groove part. For example, FIG. 8C illustrates a groove-shaped medicine holding portion 18 (184) provided along the circumference of the inner side surface 14 of the resin ring 10. Although not shown, a groove-shaped drug holding portion provided along the circumference of the outer side surface 13 of the resin ring 10 can also be provided. The groove-shaped drug holding part 18 can be made larger than the concave drug holding part 18 so that the volume in which the drug can be put is wide, which is advantageous when it is desired to increase the dosage of the drug. In the case of tablets, since the medicine can be held only by being fitted into the groove, any number of tablets can be held at any place.
 図9に示すように、リングペッサリー1は、膣内からリングペッサリー1を取り出す時に使用される紐30を備えることができる。紐30は、後端31が樹脂リング10の取付け位置190にしっかり取り付けられており、先端32は固定されていない自由端である。紐30付きのリングペッサリー1を使用する場合、紐30は、膣91の上端に保持された樹脂リング10(図2(a))から、膣91に沿って体外まで伸びるように配置される。患者は、紐30の先端32を手で引っ張ることにより、リングペッサリー1を容易に取り出すことができる。リングペッサリー1の樹脂リング10は、小さい圧縮力で大きく変形しうるので、リングペッサリー1が膣91の上端に配置された状態で紐30を体外方向(矢印P方向)に引っ張ると、樹脂リング10は両側から膣壁95(図2(a))によって圧縮されて、細長く変形する(破線で示された樹脂リング10''を参照)。このように変形した状態で膣91を通り抜けて、体外に取り出すことができるので、取り出す時に強い痛みを感じることはない。
 紐30を備えることにより、膣内に指を挿入することなしに、リングペッサリー1を取り出すことができる。よって、リングペッサリー1の自己着脱に不慣れな患者であっても、比較的容易にリングペッサリー1を取り出すことができる。
 なお、紐30を引っ張りやすくなるように、紐30の先端32が体外に十分に露出するような長さの紐30を用いるのが好ましい。
As shown in FIG. 9, the ring pessary 1 can include a string 30 that is used when the ring pessary 1 is taken out from the vagina. The string 30 has a rear end 31 firmly attached to an attachment position 190 of the resin ring 10, and a tip 32 is a free end that is not fixed. When the ring pessary 1 with the string 30 is used, the string 30 is arranged to extend from the resin ring 10 (FIG. 2A) held at the upper end of the vagina 91 to the outside of the body along the vagina 91. The patient can easily remove the ring pessary 1 by manually pulling the tip 32 of the string 30. Since the resin ring 10 of the ring pessary 1 can be greatly deformed with a small compressive force, the resin ring 10 is pulled when the string 30 is pulled in the external direction (arrow P direction) with the ring pessary 1 placed at the upper end of the vagina 91. Is compressed from both sides by the vaginal wall 95 (FIG. 2 (a)) and deformed into an elongated shape (see the resin ring 10 ″ indicated by the broken line). In such a deformed state, it can pass through the vagina 91 and be taken out of the body, so that no strong pain is felt when taking out.
By providing the string 30, the ring pessary 1 can be taken out without inserting a finger into the vagina. Therefore, even a patient who is unaccustomed to self-removal of the ring pessary 1 can take out the ring pessary 1 relatively easily.
In addition, it is preferable to use the string 30 having such a length that the tip 32 of the string 30 is sufficiently exposed outside the body so that the string 30 can be easily pulled.
 図10(a)に示すように、リングペッサリー1’(軟質フィルム20を備えていない)は、樹脂リング10に、紐30を取り付けるための紐取付け部19を備えることができる。図10(a)に図示した紐取付け部19は、樹脂リング10の内側面14から外側面13に伸びる貫通孔から成る。この紐取付け部19に紐30を挿通して結ぶ等することにより、紐30を樹脂リング10に固定することができる。紐30を固定する際に、ほどくことができるように結ぶ等することにより、紐30を樹脂リング10に対して着脱可能に取り付けることができる。 As shown in FIG. 10A, the ring pessary 1 ′ (without the soft film 20) can include a string attachment portion 19 for attaching the string 30 to the resin ring 10. 10A includes a through hole extending from the inner side surface 14 to the outer side surface 13 of the resin ring 10. The string 30 can be fixed to the resin ring 10 by inserting the string 30 into the string attaching portion 19 and tying it. When the string 30 is fixed, the string 30 can be detachably attached to the resin ring 10 by being tied so that it can be unwound.
 紐30はどのような形態でもよいが、例えば、図11(a)に図示されているように他端31が輪になっている紐30とすることにより、紐30の着脱を容易にすることができる。この紐30を紐取付け部19に取り付ける方法を、図11(b)を参照しながら説明する。まず、紐30の先端32を、樹脂リング10の内側面14側から紐取付け部19の中に挿入し、外側面13側へと引き出す。このとき、紐30の後端31の輪は、樹脂リング10の内側面14側から飛び出した状態にしておく。その後、先端32を樹脂リング10の下面12側を通って内側面14側に方向付ける。そして、紐30の先端31を、内側面14側に飛び出した状態にされている紐30の後端31の輪の中に通してから下方向に引っ張る。これにより、紐30を紐取付け部19に簡単に取り付けることができる。また、紐30の結び目が、樹脂リング10の外側面13(膣壁と接触する)や上面11(膣円蓋に接触する)に位置しないので、膣91内の軟組織に損傷を与えにくくすることができる。 Although the string 30 may take any form, for example, as shown in FIG. 11A, the string 30 having the other end 31 formed into a ring may be used to facilitate attachment / detachment of the string 30. Can do. A method for attaching the string 30 to the string attaching portion 19 will be described with reference to FIG. First, the tip 32 of the string 30 is inserted into the string attachment portion 19 from the inner surface 14 side of the resin ring 10 and pulled out to the outer surface 13 side. At this time, the ring at the rear end 31 of the string 30 is left protruding from the inner side surface 14 side of the resin ring 10. Thereafter, the tip 32 is directed to the inner surface 14 side through the lower surface 12 side of the resin ring 10. Then, the front end 31 of the string 30 is pulled downward after passing through the ring at the rear end 31 of the string 30 that is projected to the inner surface 14 side. Thereby, the string 30 can be easily attached to the string attaching part 19. Moreover, since the knot of the string 30 is not located on the outer side surface 13 (contacts with the vagina wall) or the upper surface 11 (contacts with the vaginal vault) of the resin ring 10, it is difficult to damage the soft tissue in the vagina 91. Can do.
 紐取付け部19を設けることにより、紐30は着脱可能となるので、リングペッサリー1の自己着脱に対する患者の習熟度に合わせて、紐30を使い分けることができる。つまり、患者がリングペッサリー1の自己着脱に不慣れな間は、紐30を取付けたリングペッサリー1を使用し、自己着脱に慣れてきたら、紐30を取付けずにリングペッサリー1を使用することができる。 Since the string 30 can be attached / detached by providing the string attaching portion 19, the string 30 can be used properly according to the patient's proficiency with respect to the self attachment / detachment of the ring pessary 1. That is, while the patient is unaccustomed to self-removal of the ring pessary 1, the ring pessary 1 with the string 30 is used, and when the patient gets used to self-removal, the ring pessary 1 can be used without attaching the string 30. .
 図12(a)~(b)は、紐取付け部19の別の態様を示す。
 図12(a)のように、樹脂リング10の下面12に小さい環状突起を設けて紐取付け部19とすることができる。紐30を取り付けるには、紐取付け部19の穴(環状突起の貫通穴部分)に紐30を通してから結ぶ等すればよい。
 また、図12(b)のように、樹脂リング10の下面12に軟質フィルム20を備えたリングペッサリー1において、軟質フィルム20に穴をあけて、紐取付け部19とすることもできる。紐30を取り付けるには、この穴に紐30を通した上で、樹脂リング10に巻き付けてから結ぶ等すればよい。なお、軟質フィルム20に穴をあける場合、樹脂リング10の近傍に形成するのが好ましい。
 紐取付け部19は、図11~図12に示したような形態に限定されることなく、樹脂リング10に紐30を取り付けることができればどのような形態でもよい。
12 (a) to 12 (b) show another embodiment of the string attaching portion 19. FIG.
As shown in FIG. 12A, a small annular protrusion can be provided on the lower surface 12 of the resin ring 10 to form the string attaching portion 19. To attach the string 30, the string 30 may be tied to the hole (through hole portion of the annular protrusion) of the string attaching portion 19 after passing through the string 30.
Further, as shown in FIG. 12B, in the ring pessary 1 having the soft film 20 on the lower surface 12 of the resin ring 10, a hole can be made in the soft film 20 to form the string attaching portion 19. In order to attach the string 30, the string 30 may be passed through the hole and then wound around the resin ring 10 before being tied. In addition, when making a hole in the soft film 20, forming in the vicinity of the resin ring 10 is preferable.
The string attaching portion 19 is not limited to the form shown in FIGS. 11 to 12, and any form may be used as long as the string 30 can be attached to the resin ring 10.
 図10及び図12に示すように、紐取付け部19は、2つ以上設けられているのが好ましい。2つ以上の紐取付け部19を交互に使用することにより、紐取付け部19の劣化を遅らせて、リングペッサリー1の寿命を延ばすことができる。
 さらに、2つ以上の紐取付け部19の形成位置については、図10(b)に示すように、上面視したときの樹脂リング10の中心点Oと第1の紐取付け部19(19a)とを結ぶ第1の直線Laと、中心点Oと第2の紐取付け部19(19b)とを結ぶ第2の直線Lbとのなす角度θが60°~120°(図10(b)では、θ=90°)であるのが好ましい。角度θは、80~100°であるとより好ましく、90°であるのが最も好ましい。
 角度θが適切な角度となるように複数の紐取付け部19を配置することにより、以下に詳細に説明する理由から、樹脂リング10の形状が崩れるのを抑制することができる。
As shown in FIGS. 10 and 12, it is preferable that two or more string attaching portions 19 are provided. By using two or more string attachment portions 19 alternately, the deterioration of the string attachment portions 19 can be delayed and the life of the ring pessary 1 can be extended.
Further, as to the formation positions of the two or more string attachment portions 19, as shown in FIG. 10B, the center point O of the resin ring 10 and the first string attachment portions 19 (19a) when viewed from above. The angle θ formed by the first straight line La connecting the first point La and the second straight line Lb connecting the center point O and the second string attaching portion 19 (19b) is 60 ° to 120 ° (in FIG. 10B, θ = 90 °) is preferable. The angle θ is more preferably 80 to 100 °, and most preferably 90 °.
By arranging the plurality of string attaching portions 19 so that the angle θ is an appropriate angle, the shape of the resin ring 10 can be prevented from collapsing for the reason described in detail below.
 図10(b)に示すリングペッサリー1では、樹脂リング10は2つの紐取付け部19a、19bを備えており、それらを通る直線La、Lbのなす角度θ=90°である。治療1日目は、紐30を第1の紐取付け部19aに固定したリングペッサリー1で治療を行い、治療2日目は、紐30を第2の紐取付け部19bに固定したリングペッサリー1で治療を行う。 In the ring pessary 1 shown in FIG. 10 (b), the resin ring 10 includes two string attaching portions 19a and 19b, and an angle θ between the straight lines La and Lb passing through them is 90 °. On the first treatment day, treatment is performed with the ring pessary 1 in which the string 30 is fixed to the first string attachment portion 19a. On the second treatment day, the treatment is performed with the ring pessary 1 in which the string 30 is fixed to the second string attachment portion 19b. Give treatment.
 治療1日目が終了し、第1の紐取付け部19aに取り付けた紐30を引っ張ってリングペッサリー1を体外に取り出すと、樹脂リング10は、第1の紐取付け部19aを通る第1の直線La方向(y方向)に細長く伸びた形状に変形する(破線で示した樹脂リング10aを参照)。このとき、樹脂リング10は、y方向に引っ張られ、x方向に圧縮される。
 治療2日目が終了し、第2の紐取付け部19bに取り付けた紐30を引っ張ってリングペッサリー1を体外に取り出すと、樹脂リング10は、第2の紐取付け部19aを通る第2の直線Lb方向(x方向)に伸びた形状に変形する(一点鎖線で示した樹脂リング10bを参照)。このとき、樹脂リング10は、治療1日目とは逆に、y方向に圧縮され、x方向に引っ張られる。
When the first day of treatment is completed and the ring 30 is removed from the body by pulling the string 30 attached to the first string attaching part 19a, the resin ring 10 is moved to the first straight line passing through the first string attaching part 19a. It is deformed into a shape elongated in the La direction (y direction) (see the resin ring 10a shown by a broken line). At this time, the resin ring 10 is pulled in the y direction and compressed in the x direction.
When the second day of treatment is completed and the ring 30 is removed from the body by pulling the string 30 attached to the second string attachment part 19b, the resin ring 10 becomes a second straight line passing through the second string attachment part 19a. It is deformed into a shape extending in the Lb direction (x direction) (see the resin ring 10b shown by a one-dot chain line). At this time, the resin ring 10 is compressed in the y direction and pulled in the x direction, contrary to the first treatment day.
 治療1日目に樹脂リング10に加えられたy方向への引っ張り応力とx方向への圧縮応力とによって、樹脂リング10内には「内部ひずみ」が残る可能性がある。しかしながら、治療2日目に樹脂リング10に加えられたy方向への圧縮応力とx方向への引っ張り応力とによって、治療1日目に生じた「内部ひずみ」は、相殺又は緩和されることになる。これにより、樹脂リング10の内部ひずみは、長期的に残りにくくなり、リングペッサリー1の寿命を長くすることができる。 “Internal strain” may remain in the resin ring 10 due to the tensile stress in the y direction and the compressive stress in the x direction applied to the resin ring 10 on the first day of treatment. However, the “internal strain” generated on the first day of treatment is canceled or alleviated by the compressive stress in the y direction and the tensile stress in the x direction applied to the resin ring 10 on the second day of treatment. Become. Thereby, the internal strain of the resin ring 10 is less likely to remain in the long term, and the life of the ring pessary 1 can be extended.
 なお、図10(b)では、角度θ=90°となるように2つの紐取付け部19を設けた樹脂リング10の例を示したが、角度θは90°に限定されない。例えば、角度θ=120°の場合(つまり、樹脂リング10に3つの紐取付け部19を等間隔に設けた場合)、治療1日目には第1の紐取付け部に紐30を取付けて、2日目には第2の紐取付け部、3日目には第3の紐取付け部に紐30を取付けることにより、3日間の治療で樹脂リング10の内部ひずみを相殺又は緩和することができる。また、角度θ=60°の場合(つまり、樹脂リング10に6つの紐取付け部19を等間隔に設けた場合)、6日間の治療で樹脂リング10の内部ひずみを相殺又は緩和することができる。 In addition, in FIG.10 (b), although the example of the resin ring 10 which provided the two string attachment parts 19 so that it might become angle (theta) = 90 degrees was shown, angle (theta) is not limited to 90 degrees. For example, in the case of an angle θ = 120 ° (that is, when three string attachment portions 19 are provided at equal intervals on the resin ring 10), on the first day of treatment, the string 30 is attached to the first string attachment portion, By attaching the string 30 to the second string attachment part on the second day and the third string attachment part on the third day, the internal strain of the resin ring 10 can be offset or alleviated by treatment for three days. . Further, when the angle θ = 60 ° (that is, when six string attaching portions 19 are provided at equal intervals on the resin ring 10), the internal strain of the resin ring 10 can be offset or alleviated by treatment for 6 days. .
 このように、角度θ=60°~120°であると、患者自身が、紐30を取り付ける紐取付け部19を日々変えて2日間~6日間のリングペッサリー1による子宮脱又は子宮下垂の治療を行うだけで、樹脂リング10の内部ひずみを相殺又は緩和することができる。 As described above, when the angle θ is 60 ° to 120 °, the patient himself changes the lace attachment portion 19 to which the lace 30 is attached every day to treat the uterine prolapse or uterus with the ring pessary 1 for 2 to 6 days. It is possible to cancel or alleviate the internal strain of the resin ring 10 only by performing it.
 図13に示すように、リングペッサリー1は、膣内からリングペッサリー1を取り出す時に使用される棒状の突起部22を備えることができる。なお、突起部22は、断面が矩形、円形、楕円形等の様々な形態の棒状部材から形成することができる。突起部22は、中空でも中実でもよい。
 棒状の突起部22は、その一端が軟質フィルム20の下面21に固定され、他端が下向きに伸びた状態で、リングペッサリー1に設けることができる。このリングペッサリー1を膣円蓋93(図2)に設置すると、軟質フィルム20の下面21が膣91側に配置され、軟質フィルム20の下面21に固定された突起部22は、膣91内で下向きに突出した状態になる。
 突起部22を備えたリングペッサリー1を体内から取り出す場合、指を膣内に挿入して、指先で突起部22を把持して引っ張る。突起部22は膣91内で下向きに突出しているので、指を膣91に浅く挿入すれば、指先で突起部22を掴むことができる。そのため、不慣れな患者であっても、比較的容易にリングペッサリー1を取り出すことができる。
As shown in FIG. 13, the ring pessary 1 can include a rod-shaped protrusion 22 that is used when the ring pessary 1 is taken out from the vagina. In addition, the protrusion part 22 can be formed from the rod-shaped member of various forms, such as a rectangle, circular shape, and an ellipse, in cross section. The protrusion 22 may be hollow or solid.
The rod-shaped protrusion 22 can be provided on the ring pessary 1 with one end fixed to the lower surface 21 of the soft film 20 and the other end extending downward. When the ring pessary 1 is installed on the vaginal lid 93 (FIG. 2), the lower surface 21 of the soft film 20 is disposed on the vagina 91 side, and the protrusion 22 fixed to the lower surface 21 of the soft film 20 It protrudes downward.
When taking out the ring pessary 1 provided with the protrusion 22 from the body, a finger is inserted into the vagina, and the protrusion 22 is grasped and pulled by the fingertip. Since the protrusion 22 protrudes downward in the vagina 91, if the finger is inserted into the vagina 91 shallowly, the protrusion 22 can be grasped by the fingertip. Therefore, the ring pessary 1 can be taken out relatively easily even by an inexperienced patient.
 突起部22の表面には、滑り止め23を設けることができる。突起部22を指先で掴んで引っ張る時に、指先が体液等で滑るのを抑制することができる。滑り止め23は、突起部22の表面に設けた帯状に伸びる凸部、島状の凸部、溝部など、様々な形態にすることができる。特に、図13に示すように、棒状の突起部22を囲んで延在する帯状の凸部から成る滑り止め23が好ましい。 A slip stopper 23 can be provided on the surface of the protrusion 22. When the protrusion 22 is grasped and pulled by the fingertip, the fingertip can be prevented from sliding with body fluid or the like. The anti-slip 23 can be in various forms such as a belt-like convex portion provided on the surface of the protruding portion 22, an island-shaped convex portion, and a groove portion. In particular, as shown in FIG. 13, a non-slip 23 comprising a belt-like convex portion extending around the rod-like projection 22 is preferable.
 突起部22には、リングペッサリー1を取り出す時に使用する紐を取り付けることもできる。例えば、突起部22に紐を結び付けることができる。紐は、突起部22から膣91に沿って、体外まで延在させることができる。患者は、体外に露出した紐の端部を手で引っ張ることにより、紐を介して突起部22を引っ張って、リングペッサリー1を取り出すことができる。突起部22に紐を取り付けることにより、リングペッサリー1の取出し時に膣内に指を入れる必要がなくなる。
 突起部22に滑り止め23を設けている場合には、滑り止め23より上側で、突起部22に紐を結びつけるのが好ましい。リングペッサリー1を取出すために紐を引っ張ったとき、紐が滑り止め23に引っかかって、紐が突起部22から抜けるのを抑制することができる。
A string used when the ring pessary 1 is taken out can be attached to the protrusion 22. For example, a string can be tied to the protrusion 22. The string can be extended from the protrusion 22 along the vagina 91 to the outside of the body. The patient can pull out the ring pessary 1 by pulling the protrusion 22 through the string by manually pulling the end of the string exposed outside the body. By attaching a string to the protrusion 22, it is not necessary to put a finger into the vagina when the ring pessary 1 is taken out.
In the case where the protrusion 22 is provided with the anti-slip 23, it is preferable that a string is tied to the protrusion 22 above the anti-slip 23. When the string is pulled to take out the ring pessary 1, it is possible to prevent the string from being caught by the anti-slip 23 and coming out of the protrusion 22.
 図13に示すリングペッサリー1では、突起部22は、軟質フィルム20の中心位置に固定されているが、これに限定されない。例えば、図13のように、突起部22は、軟質フィルム20のy方向において中心からずれた位置で、軟質フィルム20に固定されてもよい。また、図13に示すように、突出部22が垂直下向きに伸びる形態以外にも、図14に示すように、突出部22が傾いて伸びる形態にすることもできる。このように突出部22が傾いたリングペッサリー1を装着する場合、突出部22の傾斜方向が、身体の前面側と一致するような向きでリングペッサリー1を膣91内に設置するのが好ましい。これにより、突出部22の突出方向(身体の前側下向き)を、膣91の内腔の解剖学的形態(膣上端から膣口に向かって前面下向きに傾いている)に適合させることができる。また、リングペッサリー1を膣91から取り出すときに、突起部22が膣91の内腔と同じ方向に延在するので、突起部22を膣91の解剖学的形態に沿って引っ張るのが容易になり、リングペッサリー1を取り出しがスムーズになり得る。 In the ring pessary 1 shown in FIG. 13, the protrusion 22 is fixed at the center position of the flexible film 20, but is not limited to this. For example, as shown in FIG. 13, the protrusion 22 may be fixed to the soft film 20 at a position shifted from the center in the y direction of the soft film 20. Further, as shown in FIG. 13, in addition to the form in which the protrusion 22 extends vertically downward, the protrusion 22 can be inclined and extended as shown in FIG. When the ring pessary 1 with the protruding portion 22 inclined as described above is mounted, the ring pessary 1 is preferably installed in the vagina 91 so that the inclined direction of the protruding portion 22 coincides with the front side of the body. Thereby, the protrusion direction (downward front side of the body) of the protrusion 22 can be adapted to the anatomical form of the lumen of the vagina 91 (inclined downward from the vagina toward the vaginal opening). Further, when the ring pessary 1 is taken out from the vagina 91, the protrusion 22 extends in the same direction as the lumen of the vagina 91, so that it is easy to pull the protrusion 22 along the anatomy of the vagina 91. The ring pessary 1 can be taken out smoothly.
 また、図15、図16のように、下方向に伸びた部分を有する軟質フィルム20に、突起部22を設けることもできる。例えば、図15のリングペッサリー1では、図6(a)に示すような形態の軟質フィルム20を有し、軟質フィルム20の最下点(伸びた部分の中央近傍)に、突起部22が固定されている。図16のリングペッサリー1では、図6(b)に示すような形態の軟質フィルム20を有し、軟質フィルム20の最下点(y方向において軟質フィルム20の中心位置からずれた点)に、突起部22が固定されている。図15、16のリングペッサリー1を、膣内に配置すると、突起部22が膣口近傍に位置するので、リングペッサリー1を体内から取り出すときに、指を膣口近傍に浅く挿入するだけで、指先で突起部22を掴むことができる。そのため、不慣れな患者であっても、容易にリングペッサリー1を取り出すことができる。 Further, as shown in FIGS. 15 and 16, the protrusion 22 can be provided on the soft film 20 having a portion extending downward. For example, the ring pessary 1 shown in FIG. 15 has a soft film 20 having a configuration as shown in FIG. 6A, and a protrusion 22 is fixed to the lowest point of the soft film 20 (near the center of the extended portion). Has been. In the ring pessary 1 of FIG. 16, it has the soft film 20 of the form as shown in FIG.6 (b), and is at the lowest point of the soft film 20 (point shifted from the center position of the soft film 20 in the y direction). The protrusion 22 is fixed. When the ring pessary 1 of FIGS. 15 and 16 is placed in the vagina, the protrusion 22 is located in the vicinity of the vaginal opening, so when removing the ring pessary 1 from the body, just inserting the finger shallowly near the vaginal opening, The protrusion 22 can be grasped with a fingertip. Therefore, the ring pessary 1 can be easily taken out even by an inexperienced patient.
 以下に、リングペッサリー1の構成部材について詳述する。 The components of the ring pessary 1 will be described in detail below.
(樹脂リング10)
 樹脂リング10は、内部に貫通穴のあるリング状部材である。樹脂リング10の各寸法は、例えば、外直径OD=5~9cm、幅W=0.5cm~1cm、厚さT=0.2cm~0.6cmとすることができる。樹脂リング10の圧縮荷重(=外直径ODを、外寸法DD=2cmまで圧縮するのに必要な荷重)は2~10Nであり、指先で大きく変形させることができる。
 樹脂リング10は、生体適合性の弾性材料から形成されており、例えばシリコーンゴム、ナイロン、ポリ塩化ビニルなどの高分子材料が好適である。
(Resin ring 10)
The resin ring 10 is a ring-shaped member having a through hole inside. The dimensions of the resin ring 10 can be, for example, an outer diameter OD = 5 to 9 cm, a width W = 0.5 cm to 1 cm, and a thickness T = 0.2 cm to 0.6 cm. The compression load of the resin ring 10 (= the load necessary for compressing the outer diameter OD to the outer dimension DD = 2 cm) is 2 to 10 N, and can be greatly deformed by the fingertip.
The resin ring 10 is formed of a biocompatible elastic material, and for example, a polymer material such as silicone rubber, nylon, and polyvinyl chloride is suitable.
(軟質フィルム20)
 軟質フィルム20は、樹脂リング10内側の空洞部分を下面11側から覆って、液体等を受容するためのものである。軟質フィルム20は、液体を受容するものであるので、基本的には穴がないのが望ましい。しかし、受容する液体の量はそれほど多くないため、例えば紐取付け部19を設けるため等の目的のために、部分的に穴をあけてもよい。なお、穴をあける場合には、軟質フィルム20の中央を避けて、樹脂リング10の近傍にあけると、液体を受容する機能が損なわれにくい。
 軟質フィルム20は、中央が垂れ下がるような形状に成型されていると、液体を受容しやすくなるので好ましい。
 軟質フィルム20は、生体適合性の膜材料から形成されており、例えばシリコーンゴム膜、ナイロン膜、ポリ塩化ビニル膜などの高分子材料膜が好適である。
(Soft film 20)
The soft film 20 is for receiving a liquid or the like by covering the hollow portion inside the resin ring 10 from the lower surface 11 side. Since the flexible film 20 receives liquid, it is basically desirable that there is no hole. However, since the amount of liquid to be received is not so large, for example, for the purpose of providing the string attaching portion 19, a hole may be partially formed. In addition, when opening a hole, avoiding the center of the soft film 20 and making it in the vicinity of the resin ring 10, it is difficult to impair the function of receiving the liquid.
It is preferable that the flexible film 20 is molded into a shape that hangs down at the center, because the liquid can be easily received.
The flexible film 20 is made of a biocompatible film material, and a polymer material film such as a silicone rubber film, a nylon film, or a polyvinyl chloride film is preferable.
 (突起部22、滑り止め23)
 突起部22、滑り止め部23は、生体適合性の材料から形成されており、例えばシリコーンゴム、ナイロン、ポリ塩化ビニル、熱可塑性エラストマーなどの高分子材料が好適である。
 突起部22、滑り止め12を、軟質フィルム20に使用するのと同じ材料から形成することにより、突起部22、滑り止め12、及び軟質フィルム20を一体に成形することができる。
 なお、突起部22、滑り止め12を、軟質フィルム20に使用するのと異なる材料としてもよい。その場合には、軟質フィルム20と、突起部22、滑り止め12とを別々に成形し、後で軟質フィルム20の下面21に突起部22の一端を固定すればよい。
(Protrusion 22, anti-slip 23)
The protrusion 22 and the anti-slip portion 23 are made of a biocompatible material, and for example, a polymer material such as silicone rubber, nylon, polyvinyl chloride, and thermoplastic elastomer is suitable.
By forming the protrusion 22 and the slip stopper 12 from the same material as that used for the soft film 20, the protrusion 22, the slip stopper 12 and the soft film 20 can be formed integrally.
The protrusion 22 and the anti-slip 12 may be made of a material different from that used for the soft film 20. In that case, what is necessary is just to shape | mold the soft film 20, the protrusion part 22, and the anti-slip | skid 12 separately, and to fix the end of the protrusion part 22 to the lower surface 21 of the soft film 20 later.
(紐30)
 紐30は、患者がリングペッサリー1を体外に取り出すのを容易にするために用いられる。リングペッサリー1の取り出し中に紐30が切れないように、紐30は引っ張り強度が十分に高い材料から形成される。また、紐30は体液に接触する部材であるので、体液との接触によって引っ張り強度が低下する等の問題が起こりにくい材料から形成するのが好ましい。また、紐30が膣91内を移動するときに、膣壁95等を傷つけることのないように、ある程度の太さと柔らかさを有する材料から形成されているのが好ましい。
 紐30は、生体適合性の紐状材料から形成されており、例えば、綿、絹等の天然材料から成る紐状材料や、シリコーンゴム膜、ナイロン、ポリ塩化ビニル膜などの高分子材料から成る紐状材料が好適である。
(String 30)
The string 30 is used to make it easy for the patient to take the ring pessary 1 out of the body. The string 30 is formed of a material having a sufficiently high tensile strength so that the string 30 is not cut during the removal of the ring pessary 1. Moreover, since the string 30 is a member that contacts body fluid, it is preferably formed from a material that does not easily cause problems such as a decrease in tensile strength due to contact with the body fluid. Further, it is preferable that the string 30 is made of a material having a certain thickness and softness so as not to damage the vagina wall 95 and the like when moving in the vagina 91.
The string 30 is formed from a biocompatible string-like material, for example, a string-like material made of a natural material such as cotton or silk, or a polymer material such as a silicone rubber film, nylon, or polyvinyl chloride film. A string-like material is preferred.
(実施例1)
 リングペッサリー1に使用される樹脂リング10について、外寸法2cmにするのに必要な圧縮荷重を測定した。測定試料として、シリコーンゴム製の樹脂リング10を用いた。樹脂リング10は、外直径OD=7cmで、その断面形状は、幅方向に長い長方形(幅W=0.8cm、厚さT=0.4cm)であった。樹脂リング10の圧縮荷重測定は、JIS K 6254:2010「加硫ゴム及び熱可塑性ゴム-応力・ひずみ特性の求め方」で行った。測定は、樹脂リング10に対して直径方向に荷重をかけて(負荷過程)、外寸法7cm(荷重なし)から2cmまで圧縮した(変位5cm)。その後、徐々に荷重を減らした(除荷過程)。試験速度(外寸法の変形速度)は20cm/分とした。つまり、負荷過程15秒、除荷過程15秒であった。
Example 1
About the resin ring 10 used for the ring pessary 1, the compression load required to make the outer dimension 2 cm was measured. A silicone rubber resin ring 10 was used as a measurement sample. The resin ring 10 had an outer diameter OD = 7 cm, and its cross-sectional shape was a rectangle (width W = 0.8 cm, thickness T = 0.4 cm) long in the width direction. The compression load of the resin ring 10 was measured in accordance with JIS K 6254: 2010 “Vulcanized rubber and thermoplastic rubber-Determination of stress / strain characteristics”. In the measurement, a load was applied to the resin ring 10 in the diameter direction (loading process), and the outer dimension was compressed from 7 cm (no load) to 2 cm (displacement 5 cm). Thereafter, the load was gradually reduced (unloading process). The test speed (deformation speed of the outer dimension) was 20 cm / min. That is, the loading process was 15 seconds and the unloading process was 15 seconds.
 実施例1の実験結果を図17に示す。図17は、負荷過程と除荷過程を示すヒステリシス-ロス曲線である。負荷過程において、変位5cm(外寸法2cm)にするために必要な荷重は5.34N(約0.54kgf)であった。また、除荷直後の樹脂リング10は、約1cmのひずみが残っていた。つまり、樹脂リング10は外直径OD=7cmで、除荷直後の外寸法DD=約6cmであるので、復元率は約85%であった。 The experimental results of Example 1 are shown in FIG. FIG. 17 is a hysteresis-loss curve showing the loading process and the unloading process. In the loading process, the load required to make the displacement 5 cm (outer dimension 2 cm) was 5.34 N (about 0.54 kgf). Further, the resin ring 10 immediately after unloading had a strain of about 1 cm. That is, since the resin ring 10 has an outer diameter OD = 7 cm and the outer dimension DD immediately after unloading is about 6 cm, the restoration rate was about 85%.
(比較例1)
 比較例として、市販されているリングペッサリー(株式会社北里メディカル社製、商品名「キタザトリングペッサリー」)について、外寸法2cmにするのに必要な圧縮荷重を測定した。使用したリングペッサリーは、ナイロン樹脂請のOタイプのリングペッサリーであった(以下「リング試料」と称する)を用いた。リング試料は外直径OD=7cmで、その断面形状は円形(直径=1cm)であった。リング試料の圧縮荷重測定は、実施例1と同様であった。
(Comparative Example 1)
As a comparative example, for a commercially available ring pessary (made by Kitasato Medical Co., Ltd., trade name “Kitaza Tring Pessary”), a compressive load necessary to make the outer dimension 2 cm was measured. The ring pessary used was a nylon resin contract O-type ring pessary (hereinafter referred to as “ring sample”). The ring sample had an outer diameter OD = 7 cm and its cross-sectional shape was circular (diameter = 1 cm). The compression load measurement of the ring sample was the same as in Example 1.
 比較例1の実験結果を図18に示す。図18は、負荷過程と除荷過程を示すヒステリシス-ロス曲線である。負荷過程において、変位5cm(外寸法2cm)にするために必要な荷重は37.5N(3.82kgf)であった。また、除荷直後の樹脂リング10は、約0.1cmのひずみが残っていた。つまり、樹脂リング10は外直径OD=7cmで、除荷直後の外寸法DD=約6.9cmであるので、復元率は約98%であった。 The experimental results of Comparative Example 1 are shown in FIG. FIG. 18 is a hysteresis-loss curve showing the loading process and the unloading process. In the loading process, the load required to make the displacement 5 cm (outer dimension 2 cm) was 37.5 N (3.82 kgf). Further, the resin ring 10 immediately after unloading had a strain of about 0.1 cm. That is, since the resin ring 10 has an outer diameter OD = 7 cm and the outer dimension DD immediately after unloading is approximately 6.9 cm, the restoration rate is approximately 98%.
 実施例1と比較例1との実験結果を比較すると、実施例1の樹脂リング10は、圧縮荷重5.34N(重量換算で550g程度)であるので、女性患者の指先で負荷をかけて、十分に変形させ得ることがわかる。一方、比較例1のリング試料は、圧縮荷重37.5N(重量換算で4kg弱)であり、女性患者の指先で容易に変形させることはできないことがわかる。 When the experimental results of Example 1 and Comparative Example 1 are compared, the resin ring 10 of Example 1 has a compression load of 5.34 N (about 550 g in terms of weight). It can be seen that it can be sufficiently deformed. On the other hand, the ring sample of Comparative Example 1 has a compressive load of 37.5 N (a little less than 4 kg in terms of weight), and it can be seen that it cannot be easily deformed by the fingertip of a female patient.
  1、1’ リングペッサリー
  10 樹脂リング
  18 薬剤保持部
  19 紐取付け部
  20 軟質フィルム
  22 引き抜き部
  30 紐
  OD 樹脂リングの外直径
  DD 樹脂リングの外寸法
1, 1 'ring pessary 10 resin ring 18 drug holding part 19 string attachment part 20 soft film 22 pull-out part 30 string OD outer diameter of resin ring DD outer dimension of resin ring

Claims (10)

  1.  子宮下部を支持して子宮脱又は子宮下垂を抑制するための子宮脱又は子宮下垂治療用リングペッサリーであって、
     前記リングペッサリーは樹脂リングを含み、
     前記樹脂リングの外直径が5~9cmで、前記外直径を2cmまで圧縮するのに必要な荷重が2~10Nであり、
     除荷後30秒における前記樹脂リングの外寸法が、前記樹脂リングの前記外直径の70%以上であることを特徴とするリングペッサリー。
    A ring pessary for treating uterine prolapse or uterine droop for supporting the lower uterus and suppressing uterine prolapse or uterine drooping,
    The ring pessary includes a resin ring,
    The outer diameter of the resin ring is 5 to 9 cm, and the load required to compress the outer diameter to 2 cm is 2 to 10 N.
    A ring pessary characterized in that an outer dimension of the resin ring 30 seconds after unloading is 70% or more of the outer diameter of the resin ring.
  2.  前記樹脂リングは、略長方形の断面形状を有することを特徴とする請求項1に記載のリングペッサリー。 The ring pessary according to claim 1, wherein the resin ring has a substantially rectangular cross-sectional shape.
  3.  前記樹脂リングは、直線状の外側面と、上に凸の曲線状の上面とを含む断面形状を有することを特徴とする請求項1に記載のリングペッサリー。 The ring pessary according to claim 1, wherein the resin ring has a cross-sectional shape including a linear outer surface and a curved upper surface convex upward.
  4.  前記樹脂リングの下面側開口を覆う軟質フィルムをさらに備えることを特徴とする請求項1~3のいずれか1項に記載のリングペッサリー。 The ring pessary according to any one of claims 1 to 3, further comprising a soft film that covers an opening on a lower surface side of the resin ring.
  5.  前記樹脂リングは、薬剤を保持する薬剤保持部を備えることを特徴とする請求項1~4のいずれか1項に記載のリングペッサリー。 The ring pessary according to any one of claims 1 to 4, wherein the resin ring includes a medicine holding portion for holding a medicine.
  6.  リングペッサリー取出し用の紐をさらに備えていることを特徴とする請求項1~5のいずれか1項に記載のリングペッサリー。 The ring pessary according to any one of claims 1 to 5, further comprising a string for taking out the ring pessary.
  7.  前記リングペッサリーは、前記紐を取り付けるための紐取付け部を備え、
     前記紐は、前記紐取付け部に着脱可能に取り付けられていることを特徴とする請求項6に記載のリングペッサリー。
    The ring pessary includes a string attaching portion for attaching the string,
    The ring pessary according to claim 6, wherein the string is detachably attached to the string attaching part.
  8.  前記樹脂リングは、2つ以上の前記紐取付け部を備えており、
     前記樹脂リングの中心点と第1の紐取付け部とを結ぶ第1の直線と、前記中心点と第2の紐取付け部とを結ぶ第2の直線とのなす角度が60°~120°であることを特徴とする請求項7に記載のリングペッサリー。
    The resin ring includes two or more string attachment portions,
    The angle formed by the first straight line connecting the center point of the resin ring and the first string attaching portion and the second straight line connecting the center point and the second string attaching portion is 60 ° to 120 °. 8. The ring pessary according to claim 7, wherein the ring pessary is provided.
  9.  リングペッサリー取出し用の突起部をさらに備えていることを特徴とする請求項1~6のいずれか1項に記載のリングペッサリー。 The ring pessary according to any one of claims 1 to 6, further comprising a protrusion for taking out the ring pessary.
  10.  前記突起部は、前記樹脂リングの下面側開口を覆う軟質フィルムの下面側に設けられていることを特徴とする請求項9に記載のリングペッサリー。 The ring pessary according to claim 9, wherein the protrusion is provided on a lower surface side of a soft film that covers an opening on a lower surface side of the resin ring.
PCT/JP2014/074962 2013-09-20 2014-09-19 Ring pessary for treatment of uterine prolapse or hysteroptosis WO2015041353A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015537993A JPWO2015041353A1 (en) 2013-09-20 2014-09-19 Ring pessary for uterine prolapse or uterine droop treatment

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013195182 2013-09-20
JP2013-195182 2013-09-20

Publications (1)

Publication Number Publication Date
WO2015041353A1 true WO2015041353A1 (en) 2015-03-26

Family

ID=52689000

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2014/074962 WO2015041353A1 (en) 2013-09-20 2014-09-19 Ring pessary for treatment of uterine prolapse or hysteroptosis

Country Status (2)

Country Link
JP (1) JPWO2015041353A1 (en)
WO (1) WO2015041353A1 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017031456A1 (en) 2015-08-20 2017-02-23 Watkins-Conti Products, Inc. Flexible cone-shaped intra-vaginal support device
KR101806732B1 (en) * 2016-08-25 2017-12-07 고려대학교 산학협력단 Cervical bandage for prevention of preterm birth
KR20170139279A (en) * 2016-06-09 2017-12-19 고려대학교 산학협력단 Surgical closure of incompetent cervix for strap
KR101866665B1 (en) * 2016-11-09 2018-06-11 고려대학교 산학협력단 Device for surgical closure of incompetent cervix
WO2019083071A1 (en) * 2017-10-27 2019-05-02 고려대학교 산학협력단 Cervical band structure for preventing preterm birth resulting from cervical weakness
EP3337434A4 (en) * 2015-08-20 2019-06-05 Watkins-Conti Products, Inc. Flexible cone-shaped intra-vaginal support device
WO2021069619A1 (en) * 2019-10-08 2021-04-15 Gruenspecht Naturprodukte Gmbh Menstrual cup
KR20210066428A (en) * 2019-11-28 2021-06-07 인제대학교 산학협력단 Menstrual cup
US11291535B2 (en) 2018-03-16 2022-04-05 Watkins-Conti Products, Inc. Intravaginal support devices and methods
KR20220131643A (en) * 2021-03-22 2022-09-29 가톨릭대학교 산학협력단 Customized pessary for preventing premature bityh and its manufacturing method

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2234495A (en) * 1940-03-18 1941-03-11 Willard V Lay Pessary
JPS5164793A (en) * 1974-10-18 1976-06-04 Schering Ag
JPS63145651A (en) * 1986-07-24 1988-06-17 ヤマ インコーポレイティド Female contraceptive
US5295984A (en) * 1989-12-07 1994-03-22 Ultrafem, Inc. Vaginal discharge collection device and intravaginal drug delivery system
JPH10504205A (en) * 1994-06-29 1998-04-28 リプロテクト エルエルシー Apparatus and method for acidic buffer
JP2011167364A (en) * 2010-02-19 2011-09-01 Kenji Ishii Pessary
JP2011530379A (en) * 2008-08-12 2011-12-22 テバ ウィメンズ ヘルス インコーポレイテッド Intravaginal device having a rigid support, method of making, and use thereof
US20120259159A1 (en) * 2011-04-11 2012-10-11 Nancy Karapasha Pessary device
JP2012527985A (en) * 2009-05-28 2012-11-12 コンタイン コーポレーション Correction of stress urinary incontinence

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2234495A (en) * 1940-03-18 1941-03-11 Willard V Lay Pessary
JPS5164793A (en) * 1974-10-18 1976-06-04 Schering Ag
JPS63145651A (en) * 1986-07-24 1988-06-17 ヤマ インコーポレイティド Female contraceptive
US5295984A (en) * 1989-12-07 1994-03-22 Ultrafem, Inc. Vaginal discharge collection device and intravaginal drug delivery system
JPH10504205A (en) * 1994-06-29 1998-04-28 リプロテクト エルエルシー Apparatus and method for acidic buffer
JP2011530379A (en) * 2008-08-12 2011-12-22 テバ ウィメンズ ヘルス インコーポレイテッド Intravaginal device having a rigid support, method of making, and use thereof
JP2012527985A (en) * 2009-05-28 2012-11-12 コンタイン コーポレーション Correction of stress urinary incontinence
JP2011167364A (en) * 2010-02-19 2011-09-01 Kenji Ishii Pessary
US20120259159A1 (en) * 2011-04-11 2012-10-11 Nancy Karapasha Pessary device

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016308363B2 (en) * 2015-08-20 2020-08-27 Watkins-Conti Products, Inc. Flexible cone-shaped intra-vaginal support device
CN111658289A (en) * 2015-08-20 2020-09-15 沃特金斯-康迪产品股份有限公司 Flexible conical vaginal support device
CN108135732A (en) * 2015-08-20 2018-06-08 沃特金斯-康迪产品股份有限公司 Flexible conical intravaginal support device
US11219548B2 (en) 2015-08-20 2022-01-11 Watkins-Conti Products, Inc. Flexible cone-shaped intra-vaginal support device
JP2018526169A (en) * 2015-08-20 2018-09-13 ワトキンス−コンティ プロダクツ, インコーポレイテッド Flexible conical intravaginal support device
WO2017031456A1 (en) 2015-08-20 2017-02-23 Watkins-Conti Products, Inc. Flexible cone-shaped intra-vaginal support device
EP3337434A4 (en) * 2015-08-20 2019-06-05 Watkins-Conti Products, Inc. Flexible cone-shaped intra-vaginal support device
KR20170139279A (en) * 2016-06-09 2017-12-19 고려대학교 산학협력단 Surgical closure of incompetent cervix for strap
KR102586182B1 (en) * 2016-06-09 2023-10-06 고려대학교 산학협력단 Surgical closure of incompetent cervix for strap
KR101806732B1 (en) * 2016-08-25 2017-12-07 고려대학교 산학협력단 Cervical bandage for prevention of preterm birth
KR101866665B1 (en) * 2016-11-09 2018-06-11 고려대학교 산학협력단 Device for surgical closure of incompetent cervix
KR20190047481A (en) * 2017-10-27 2019-05-08 고려대학교 산학협력단 cervical bandage for prevention of preterm birth
WO2019083071A1 (en) * 2017-10-27 2019-05-02 고려대학교 산학협력단 Cervical band structure for preventing preterm birth resulting from cervical weakness
KR102110132B1 (en) * 2017-10-27 2020-05-13 고려대학교산학협력단 cervical bandage for prevention of preterm birth
US11291535B2 (en) 2018-03-16 2022-04-05 Watkins-Conti Products, Inc. Intravaginal support devices and methods
WO2021069619A1 (en) * 2019-10-08 2021-04-15 Gruenspecht Naturprodukte Gmbh Menstrual cup
KR20210066428A (en) * 2019-11-28 2021-06-07 인제대학교 산학협력단 Menstrual cup
KR102328099B1 (en) * 2019-11-28 2021-11-17 인제대학교 산학협력단 Menstrual cup
KR102571791B1 (en) 2021-03-22 2023-08-28 가톨릭대학교 산학협력단 Customized pessary for preventing premature bityh and its manufacturing method
KR20220131643A (en) * 2021-03-22 2022-09-29 가톨릭대학교 산학협력단 Customized pessary for preventing premature bityh and its manufacturing method

Also Published As

Publication number Publication date
JPWO2015041353A1 (en) 2017-03-02

Similar Documents

Publication Publication Date Title
WO2015041353A1 (en) Ring pessary for treatment of uterine prolapse or hysteroptosis
US8302608B2 (en) Vaginal pessary
JP5371825B2 (en) pessary
US20140083433A1 (en) Inflatable multilevel vaginal pessary device
US20220175573A1 (en) Hannah Cervical Cup
US20190029874A1 (en) Vaginal ring removal device and methods
US11331213B2 (en) Devices and methods for pelvic organ prolapse alleviation
US10188426B2 (en) Embryo transfer catheter and method
WO2018213187A1 (en) Pessary systems and methods
EP1539062B1 (en) Soft cling female condom
US6251067B1 (en) Male erectile prosthesis
WO2017064714A1 (en) Devices and methods for pelvic organ prolapse alleviation
CN206403917U (en) A kind of restricted gloves for medical treatment
US10052225B2 (en) Drug-dispensing ring removal tool
JPWO2016093315A1 (en) Defecation bag and method for producing defecation bag
WO2017184669A1 (en) Intrauterine adhesion barrier device and method of use
US8490625B2 (en) Intrauterine device string
US2519712A (en) Constrictor
CN105025849B (en) The ergonomics protection housing apparatus of perineum orthopedic type
KR101656170B1 (en) Pessary for care pelvic organ prolapse
US20140345624A1 (en) Intrauterine Device Remover
CN219557699U (en) Perianal tissue protection device for delivery
CN211325993U (en) Local pressurization support for inguinal hernia
CN204092826U (en) Prevent uterine cavity and cervical canal adhesion device simultaneously
JP2016002192A (en) In-vagina medication assisting tool

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14845700

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2015537993

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14845700

Country of ref document: EP

Kind code of ref document: A1